Search results


1350 results for “”.
Join us to reshape and prolong the lives
Built on MicroPort legacy of advancing medical technology, our teams continue to solve the most difficult challenges to treating disease and extending life.
Zhaohua Chang
Norihiro Ashidaéé-kurogi
Yasuhisa Kurogi
About Us
MicroPort® is a global medical devices company, founded on the belief that every person has the right to high quality medical treatments and to live longer and...
Purpose and Values | Reshape and prolong life for everyone
We deeply understand our products are directly related to patients’ lives, and even the slightest deviation could cause significant impact. Because of this...
Leadership Team
To build a company that legitimately elevates the standards of its industry, one critical success factor is strong, intelligent, and insightful leadership...
Investor Relations
Shanghai Pudong New Area Zhangjiang Science City. Relentless innovation has inspired promising product development and initiated strategic investments in...
Contact us
Today, MicroPort operates in multiple international markets across multiple fields, including orthopedics, cardiovascular intervention, cardiac rhythm management...
Healthcare Professionals
From our global vantage point we’re witnessing an extraordinary transformation – to deliver meaningful medical technology breakthroughs that improve the way we...
Сardiovascular therapeutic solutions.
Founded in 1998, as a company dedicated to making emerging minimally invasive technologies more accessible to more patients across the world. Today, MicroPort...
Orthopedics | Help patients achieve full function
At MicroPort Orthopedics, we are continually driven to leverage our extensive experience in orthopedics and 20 years of superior clinical results to improve...
Cardiac Rhythm Management
Pacemakers. ICD devices. CRT devices. A cardiac lead. MicroPort CRM provides you with SMARTVIEW – a complete solution for patient management. Arrhythmia assessment...
MicroPort is committed to providing personalized treatment programs and services to patients with aortic and peripheral diseases. Through continuous innovation we...
We are continuously collaborating with medical professionals and experts across the globe to bring the latest technologies and innovation to new therapies for...
Surgical Robots
Our innovative robots offer surgeons superior surgical outputs. Honghu Orthopedic surgery navigation and positioning system is a one-of-a-kind surgical robotic...
Other areas
MicroPort is also active in various other fields such as diabetes, having developed the La Fenice Insulin pump and the Hypophyseal Hormone Infusion pump ...
Our success comes in human measures
Everyone at MicroPort believes that health and better quality of life is an innate right to everyone. And we can see the value of innovation in the eyes of...
Coronary Artery Disease
The build up of plaque will partially or totally block blood flow in the coronary arteries of the heart, reducing the blood flow into the heart (Myocardial Ischemia).
Severe Aortic Valve Stenosis
The heart has four valves that ensure the blood circulates in one direction in an orderly fashion throughout the body. The aortic valve sits between the main pumping...
Abnormal Heartbeat (Heart Arrhythmias)
Heart arrhythmia is the absence of a normal rhythm, which means that the rhythm is either too slow or too fast. A number of symptoms are associated with arrhythmia...
Joint Replacement
It is a common condition in which cartilage breakdown around the joints causes your bones to rub together, and it is especially common in the knee and hip joint.
Hemorrhagic Stroke
A hemorrhagic stroke can be caused by hypertension, rupture of an aneurysm or vascular malformation or as a complication of anticoagulation medications.
Reshaping Health
The advancing technologies in medicine are profoundly changing our ability to improve and prolong human life. But with that extraordinary opportunity comes...
History | The ambitious pursuit of innovation
Before the world even imagined that 4 million drug-eluting stents would be available in 36 countries around the world, the founders of MicroPort® were imagining...
Hips | Help patients get home faster
With a complete focus on rapid recovery surgical approaches and implants, MicroPort has partnered with pioneering surgeons in the development of a number of...
Financial Reports
With a diversified product portfolio now being used in over 10,000 hospitals in the world, the Group maintains world-wide operations in a broad range of business...
2019 Annual Report
2019 Interim Report
Knees | The original medial-pivot knee design
The unique design and successful clinical heritage of MicroPort Orthopedics’ medial-pivot knees sets the EvolutionTM Knee System apart from the competition...
Thoracic Aortic Aneurysm
Total aortic arch replacement, refers to the use of artificial blood vessels to replace the diseased thoracic aorta. The actual surgical procedure and...
Aortic Dissection
Hercules low-profile bifurcated stent-graft system. The outer sheath diameter for 34mm stent graft is ONLY 18 Fr, allowing for enhanced maneuverability when...
Abdominal Aortic Aneurism
Endovascular Aortic Repair (EVAR) is an alternative to open surgery and has the advantage of less trauma, faster recovery, fewer complications and fewer...
Atherosclerosis Obliterans
After the treatment guide wire is inserted into the artery and reaches the designated position, the balloon catheter then reaches the lesion site utilizing the...
Our groundbreaking research has allowed us to develop the world’s smallest dual chamber pacemaker and the world's first AutoMRI technology to automatically...
ICD devices
Our ground breaking research has allowed us to develop the world’s longest lasting implantable defibrillator which embeds PARAD+, a clinically proven...
CRT devices
Platinium 4LV SonR CRT-D gives every patient a chance to become a responder thanks to multiple therapeutic options and features the world’s longest projected...
Discover the engineering excellence of our leads and how each one works to support our top-of-the-line cardiac devices. The only atrial pacing lead featuring SonR...
Patient management
From the moment of implantation and throughout the lifetime of our cardiac devices, we offer intuitive software interfaces from our programmers to our remote...
Arrhythmia assessment
With more than 30 years of experience in ECG recording tools, MicroPort CRM produces state-of-the-art technologies that are the gold standard in data acquisition...
Hemorrhagic cerebrovascular solutions
Hemorrhagic stroke is a leading cause of death across the globe, commonly caused by aneurysm ruptures. MicroPort NeuroTech is committed to foster rapid communication...
Ischemic cerebrovascular solutions
Ischemic stroke is usually caused by stenosis or occlusion of the blood artery, resulting in insufficient cerebral blood supply and subsequent necrosis of brain tissues.
Diabetes and endocrinal management
La Fenice Insulin pump is a medical aid for the treatment of diabetics, mainly suffering from diabetes mellitus. La Fenice supplies at intervals a basal dose of...
Membrane oxygenation system
The KW membrane oxygenator is used to add oxygen to, and remove carbon dioxide from the blood. It can be used in two principal modes: To imitate the function of the...
Rehabilitation and Patient Care
The DynBite Temporomandibular joint dynamic rehabilitation device is a new product developed by Suzhou MicroPort Rehab Technologies Ltd, designed to treat jaw...
Reproductive Health
The Lotus ovum aspiration needle is manufactured under the highest standard of MicroPort. With the humanized design, Lotus obtains the highest quality eggs in the...
Evermend vsd occluder
According to the variety of ventricular septum in thickness, the Evermend VSD occluders come in two variants; the Pre-membranous VSD occluder and the...
Heart Valve | Transcatheter aortic valve replacement
MicroPort CardioFlow established in 2015, is dedicated to providing advanced minimally invasive therapies for structural heart diseases. Our vision...
MicroPort has achieved several firsts and won numerous awards in recognition of its high-tech research, patent registration and advanced capabilities within the...
Aortic Aneurism
Abdominal aortic aneurysm (AAA): refers to when the diameter of abdominal aorta expands to 1.5 times the normal diameter, and is the most common artery...
Arteriosclerosis Obliterans, or peripheral artery disease (PAD), is a medical conditions that affects the whole body. ASO results from a hardening of arteries...
Strategic investments or collaborations
MicroPort has developed several strategic partners in China, United States, Europe, Singapore, and Israel. Collaborations are included across a wide range of...
Knowledge & Action Medical Training Institute
The unity of knowledge and action represents the combination MicroPort high-tech products with doctors' actions, and through academic promotion, the developed...
3D EP Navigation System Project
Atrial fibrillation is one of the most common persistent arrhythmias in clinical practice. It is a common cardiovascular disease just after hypertension and...
Branched Aortic Stent-Graft System
With the increasing incidence of atherosclerosis, the arteriectasia represented by aortic aneurysm and aortic dissection has become a common disease in China.
Stent Graft in Surgical Operation
Large vascular surgery is a curse for cardiovascular surgery because of high mortality and low cure rate. It can cause fatality in a split second. The well-known...
Intracranial Stent Graft
The cerebrovascular diseases are characterized by high treatment risk and high fatality rate. With the development of interventional therapy and surgery, it is...
Angiographic Guidewire Project
With the improvement of living standards, the incidence of coronary heart disease is increasing year by year, which has become one of the major diseases endangering...
Pituitary Hormone Infusion Pump Project
Idiopathic hypogonadotropin hypogonadism (IHH) is caused by the impaired neuron function of the congenital hypothalamus gonadotropin releasing hormone (GnRH)
Legal statement
This Website (the Site) is owned and operated by MicroPort Scientific Corporation ("MicroPort®"). Please carefully review these Terms of Use (Terms). By accessing...
International Medical Devices Company
MicroPort is an international medical devices company, founded on the belief that every person has the right to high quality medical treatments and to live longer and healthier lives.
Relentless innovation has inspired promising product development and initiated strategic investments in emerging scientific platforms. Today, we see...
A rate lower than 60 beats per minute is normal only if you are resting, asleep, or very physically fit. A heart rate below 60 beats per minute is called bradycardia.
If your heart rate is over 100 beats per minute this is called tachycardia. There are normal and abnormal fast heart rhythms. Exercise, mental or emotional stress...
Irregular Heartbeat (Atrial Fibrillation)
Atrial fibrillation (AF) is the most common arrhythmia, it occurs when the upper chambers (atria) of the heart experience chaotic electrical signals...
Understanding Total Hip Replacement
Those conditions include Osteoarthritis, Osteonecrosis, Rheumatoid Arthritis, Traumatic Arthritis or Traumatic Injury. The key is finding a way to restore your...
Understanding total knee replacement
Osteoarthritis affects nearly 350 million people worldwide. Those with osteoarthritis of the knee may experience pain, which may keep them from performing and...
Global Leadership Team
MicroPort Scientific Corporation consists of two geographically distinctive operational business units: Greater China and InterContinental, respectively managed...
ENO | One with heart
World’s smallest transvenous pacemaker. Empower AF Risk Management. Minimize ventricular pacing for SND and AVB patients. Screen and Monitor for Sleep Apnea...
SafeR allows for intelligent management
SafeR is the only AV management solution proven to reduce ventricular pacing while at the same time managing long PR intervals. Proven to be safe and effective...
Sleep Apnea Monitoring
Proactive management of comorbidities. Early detection, long-term risk reduction. Severe sleep apnea is strongly associated with and has a negative impact on...
AutoMRI | Less time, more flexibility
AutoMRI mode is the world’s first pacemaker technology capable of detecting an MRI field and automatically switching to asynchronous mode. The presence...
Dual Sensor
Physiologic rate response. Twin trace is designed to physiologically modulate the heart rhythm by combining Accelerometer and Minute Ventilation sensors...
TEO | Break free
Therapies activated automatically at implant. Minimizes ventricular pacing for SND and AV Block patients. 12 years of longevity* in 8 cc. World’s smallest...
5 things to ask your hip surgeon
Only you and your doctor can come to the conclusion of whether or not a joint replacement is the right treatment for your pain. There are many factors that...
Hip replacement FAQ
You should tell your doctor about your full medical history, even if you don’t think that something in your history is important. Tell your doctor about any and...
Five things to ask your knee surgeon
Only you and your doctor can come to the conclusion of whether or not knee replacement is the right treatment for your pain. There are many factors that can...
Knee replacement FAQ
Total knee replacement is a surgical procedure that replaces your knee joints damaged cartilage and bone with smooth metal and high-grade plastic surfaces.
Hongliang Yu
Jonathan H. Chou
Guoen Liu
Chunyang Shao
Glendy Wang
Hongbin Sun
Cardiac-Rhythm Management Leadership Team
With global headquarters in Clamart, France, state of the art manufacturing facilities In France, Italy and Dominican Republic, and a global workforce of over 950...
Qiyi Luo
Jonathan Chen
Todd Smith
Bo Peng
Yimin Xu
Chengyun Yue
Yiyun Que
Linda Lin
Benoit Clinchamps
Philippe Wanstok
Paul Vodden
Orthopedic Leadership Team
With global headquarters, manufacturing and research facilities in Arlington, Tennessee, and a global workforce of over 800, MicroPort® Orthopedics’ management...
Paul Bryant
Scott Shankle
Todd Smith
Irina Timmerman
Serge Cazeau
Daniel Kroiss
Anne-Sophie Sarrazin
Vincent Leveaux
Andrea Vinconïde-feunteun
Maïder Feunteun
2018 Interim Report
2018 Annual Report
2017 Interim Report
2017 Annual Report
2016 Interim Report
2016 Annual Report
2015 Interim Report
2015 Annual Report
2014 Interim Report
2014 Annual Report
2013 Interim Report
2013 Annual Report
2012 Interim Report
2012 Annual Report
2012 Annual report
2011 Annual Report
2011 Interim Report
2010 Interim Report
2010 Annual Report
Financial Calendar
MicroPort Scientific Corporation Global Offering. Relentless innovation has inspired promising product development and initiated strategic investments in...
Corporate Governance
To guide the operation and direction of the Board and its committees, the Board of Directors has established our terms of references for each standing committee...
Annoucement & Circulars
Press releases are available from 13 September 2010. Relentless innovation has inspired promising product development and initiated strategic investments in...
Financial Information
Turnover. Gross Profit. Research and Development Costs. Distribution Costs. Administrative Expenses. Profit for the Year. Earning per Share-Basic. Net Assets...
Corporate Social Responsibility
Наша цель - продлить и изменить жизнь с помощью самых передовых медицинских технологий в мире. Мы хотим сделать это для каждого сообщества, каждой семьи и ...
Corporate Responsibility
Our responsibility to shareholders is to enhance their asset value, delivering added-value and steady returns. MicroPort, maintains a sustained and steady...
Employer Brand Dimension
At MicroPort our talent is of the utmost importance. We provide our employees with a harmonious and positive working environment and offer attractive...
Corporate Citizenship
Responsibility to the society and communities is deeply ingrained into our corporate culture. We believe strongly in giving something back to the societies in...
MicroPort® CardioFlow Receives Approval for VitaFlow® Aortic Valve System in Argentina
MicroPort® Access Receives Approvals for Angiography Guidewire and Angiography Catheter in Brazil
MicroPort® EP Announces New Strategic Investors
MicroPort® Assisted Reproductive Technology (ART) Business Announces New Investors
MicroPort® Cardiac Rhythm Management Business Announces New Investor
MicroPort Scientific Corporation Announces Completion of Placing
MicroPort Firehawk® TARGET AC clinical study three-year results announced at PCR e-course affirms the long-term safety and effectiveness of Firehawk®
MicroPort® announces strategic collaboration on digital subtraction angiography system with Siemens Healthineers
MicroPort® Holds 2020 Annual General Meeting in Shanghai
MicroPort® Announces Strategic Investment and Forms Joint Venture with Indian Medical Device Company Purple Medical
Tigertriever® Revascularization Device Produced by Rapid Medical Ltd., an Affiliate Company of MicroPort® NeuroTech, Enters
MicroPort® Orthopedics Group Brings in New Strategic Investors
MicroPort® and NDR, a Developer of Automated Needle Targeting Robotics System, Announce Strategic Investment and Agreement to Establish a Joint Venture in China
MicroPort® and Robocath Announce Strategic Investment and Binding Term Sheet to Form a Vascular Robotics Joint Venture for the China Market
MicroPort® CardioFlow Completes Raising New Round of Funds
MicroPort® Announces Annual Results for 2019
MicroPort® EP's Remote ECG Technology Contributes to Building of Intelligent Shelter Hospital
Endovastec™ Wins 2019 Shanghai Municipal Quality Management Prize
MicroPort® EP Receives Approvals for Multiple Catheters and Other Devices in Indonesia
Endovastec™ Completes the First Implantation of Minos® Stent Graft Outside of China
MicroPort® Orthopedics' First Chinese-made Total Hip Arthroplasty System Receives NMPA Approval
Endovastec™ Wins "Pudong New Area Quality Gold Prize"
MicroPort® EP's Contact Force-Sensing RF Ablation Catheter Completes First Case in Clinical Trial
MicroPort® and Shanghai Municipal Research Center for Health Development Enter into Strategic Cooperation Agreement
MicroPort® Enters into Strategic Cooperation Agreement with Shanghai General Hospital
MicroPort® Rehab Tech Debuts at Comprehensive Academic Annual Conference of Chinese Association of Rehabilitation Medicine
MicroPort® Makes the List of First Batch of "Pudong New Area Demonstration Bases for Integration of Science & Technology Innovation and Science Communication"
Endovastec™ Minos® Stent Graft Enters 2019 Shanghai Municipal Recommendation Directory for Innovative Products
MicroPort® Attends Eleventh Left Main & Coronary Bifurcation Summit (CBS 2019)
MicroPort® Orthopedics Attends COA 2019
MicroPort® NeuroTech Attends Second Shaolin Interventional Neurosurgical Conference and 5th Central China Cerebrovascular Disease Forum
Firehawk® Project Wins 2019 PMI (China) Project Management Award – Excellent Project
MicroPort® CardioFlow Attends the Fifth Edition of PCR-CIT China Chengdu Valves
MicroPort® Won APQO Innovation Class Award 2019
MicroPort® Wins First Edition of "Shanghai Municipality Intellectual Property Innovation Award"
MicroPort® Firesorb® Pivotal Study (FUTURE III) Holds National Investigator Kick-off Meeting in Beijing
MicroPort® Exhibits VitaFlow® Integrated Solution at Third Edition of China Structure Week
Endovastec™ Post-marketing Clinical Study of Minos® Abdominal Aortic Stent-Graft and Delivery System Noted in Shanghai
Inauguration of MicroPort® Orthopedics' International Shared Services Center in Costa Rica
MicroPort® CRM Announces First Implant in Japan of the New Eno™ Pacemaker Family, World's Smallest 1.5T & 3T MRI Conditional Pacemakers*
MicroPort® CRM Japan Starts Direct Sales Operations in Japan and Launches the New ENO™ Pacemaker Family
MicroPort® Announces Interim Results for the Six Months Ended June 30, 2019
Endovastec™, a Subsidiary of MicroPort®, Listed on the STAR Market of the Shanghai Stock Exchange
MicroPort® Orthopedics Announces Launch of its Evolution® NitrX™ Knee
VitaFlow® Transcatheter Aortic Valve and Delivery System Receives NMPA Approval
MicroPort® EP Obtains Approval for OptimAblate™ Cardiac RF Generator from National Medical Products Administration of China (NMPA)
Mr. Rodrigo Pérez Estrada Joins MicroPort® as Vice President Global Branding
MicroPort® Attends the 13th Oriental Congress of Cardiology (OCC 2019)
MicroPort® NeuroTech Donates a Tubridge® Device to Successfully Save the Life of a Patient Diagnosed with Multiple Intracranial Aneurysms
MicroPort® Attends 12th Annual Conference of Chinese Association of Orthopaedic Surgeons (CAOS 2019)
MicroPort® Receives Reimbursement in France for Firehawk®
MicroPort® Announces Successful Non-Inferior Two-Year Clinical Data for its Firehawk Drug-eluting Stent at EuroPCR 2019
MicroPort® Takes Part in 2019 Yangtze River Delta Health Summit
MicroPort® EP Teams up with MicroPort® CRM to Attend Annual Meeting of the German Society of Cardiology (DGK)
MicroPort® Participates in China Brand Day
MicroPort® NeuroTech Attends the 16th Edition of China Forum of Cerebrovascular Diseases (CFCVD)
Tubridge® Holds Fifth Presentation at World Live Neurovascular Conference (WLNC)
Endovastec™ Attends the 4th Edition of Vascular Innovation Symposium (VINNOVA)
MicroPort® Attends the 22nd Edition of China Cardiovascular Intervention Forum (CCIF 2019)
MicroPort® Attends 24th Cardiovascular Summit TCTAP 2019 in Korea
MicroPort® Attends the 2019 World Health Expo
MicroPort® CardioFlow Attends the Fifth Edition of China Valve (Hangzhou) 2019
MicroPort® Orthopedics Receives NMPA Approvals for Chinese-made Wedge-Shaped Femoral Stem and Metal Femoral Head
MicroPort® MedBot's 3D Electronic Laparoscope Enters "Green Path"
MicroPort® CardioFlow Attends CSI Asia-Pacific 2019
MicroPort® Receives CE Mark for Firehawk Liberty™, a New Generation Rapamycin Target Eluting Coronary Stent System
The First Edition of MicroPort® Master Course Complex PCI Cross-Regional Program Ends Successfully
MicroPort® EP's PathBuilder™ Steerable Introducer Wins Approval from National Medical Products Administration of China (NMPA)
MicroPort® Wins the Title of Shanghai Municipality Model Unit for Six Consecutive Years
MicroPort® Makes the List of Top 20 Companies with Outstanding Contribution to Pudong New Area's Scientific and Technological Innovation in 2018
MicroPort® Medical Robotics Symposium of the Medical Engineering Committee under Shanghai Association of Integrative Medicine Took Place Successfully
MicroPort® Receives Approval to Launch ARBORES™ Kyphoplastic Balloon Catheter in China
MicroPort® Orthopedics Attends 2019 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting
MicroPort® Aspiration™ and SoSuperior™ Total Knee Replacement Systems Obtain NMPA Approvals
Endovastec™ Obtains NMPA Approval to Launch Minos™ Ultra-Low Profile Abdominal Aortic Aneurysm Stent Graft System
China Interventional Therapeutics (CIT) 2019: Innovative Products of MicroPort® Muster on Display
MicroPort® Announces Annual Results for 2018
MicroPort® Orthopedics Announces Executive Change
MicroPort® Wins the Award of Top 10 Pudong Headquarters Economy Classic Samples
MicroPort® Panoramic Endoscope Design Wins iF DESIGN AWARD 2019
MicroPort® Won 2018 Shanghai Municipality Gold Quality Prize
MicroPort® Orthopedics and School of Medical Instrument and Food Engineering of University of Shanghai for Science and Technology Held Agreement Signing and Inauguration Ceremony for Mutual Cooperation
Firehawk® and Rega® Family Implantable Pacemakers Make the List of Health China (2018) • Top 10 Medical Devices
MicroPort® Orthopedics Aspiration Medial Stability Total Knee Replacement System – PS Type Implant Obtains Approval in China
Three Subsidiaries of MicroPort® Awarded the Title of 2018 Shanghai Municipality Specialized, Refined, Characteristic and Novel Small and Medium-Size Enterprise
MicroPort® and Shanghai East Hospital Jointly Initiate the China Interventional Pulmonology Innovation Industry Alliance
MicroPort® Firehawk® Stent Pivotal Study TARGET DAPT Trial Launched at Zhongshan Hospital Affiliated to Fudan University and Completed First Enrollment
MicroPort® Firehawk® Debuts at Taiwan Transcatheter Therapeutics Live Course
MicroPort® CRM Announces First Implants of Eno™ and Teo™, World's Smallest 1.5T & 3T MRI Conditional Pacemakers*
MicroPort® Orthopedics and School of Medical Instrument and Food Engineering of University of Shanghai for Science and Technology Held Agreement Signing and Inauguration Ceremony for Mutual Cooperation
MicroPort® CRM Announces European Launch of New Tablet Programmer for Implantable Cardiac Devices
MicroPort® CRM Announces European Launch of World's Smallest 1.5T & 3T MRI Conditional Pacemaker Portfolio*
Beflex Active Pacing Lead Family Approved in China
Mr. Noboru Shimizu Joined MicroPort® CRM as Vice-President, Country Manager Japan, and Head of Commercial Operations of MicroPort® CRM Japan Co. Ltd.
MicroPort® Takes Firehawk® to Encore Seoul 2018 in Korea
MicroPort® Orthopedics Holds First University of Hong Kong - Shenzhen Hospital Total Knee Arthroplasty Technique (TKA) Advancement Course
Experts from Pakistan Society of Interventional Cardiology Visits MicroPort®
MicroPort® Firehawk® Appears at the High-level Meeting on China-Africa Health Cooperation
MicroPort® Brings Product Lines to China Heart Congress (CHC) 2018
MicroPort® Appears at China Medical Devices Design & Startups Competition & Global Device Week (2018)
MicroPort® Brings Innovative Products to TCT 2018
MicroPort® Spine Trauma's Full Series Instruments Granted Registration Approval in Brazil
Suzhou MicroPort® Orthocare Holds 1st New Rehabilitation Technique Symposium
MicroPort® CRM Announces Change in Strategic Direction for Japan CRM Market and End of Distribution Agreement with JLL in One Year's Time
MicroPort® Firefighter™ PTCA Balloon Catheter Obtains Approval for Registration in Mexico
Firehawk® Presented at the 15th Malaysian Cardiovascular Interventional Symposium with Live Transmission (MYLIVE2018)
MicroPort Sorin CRM Commemorates the Clinical Application of the First Batch of Domestically made Rega® Family Pacemakers
Shanghai MicroPort Medical (Group) Co., Ltd. Won A Patent Right Lawsuit Against NewMed Medical Co., Ltd.
MicroPort® Orthopedics Attends the First Edition of the Northeast Region Joint Surgery Summit Forum
MicroPort® Orthopedics Holds the Full Function, Faster® 2018 Didactic Conference
MicroPort® EP Obtains CFDA Approval for EasyFinder™ 3D Steerable Curve Mapping Catheter
Four MicroPort® Products Gain Regulatory Approval in Serbia
Firehawk® Gains Launch Approval in Hong Kong Public Hospitals
MicroPort® Orthopedics Attends CAOS 2018
MicroPort® Orthopedics Attends CKS 2018
Tubridge® Displayed in WLNC
MicroPort® NeuroTech Hosts Intracranial Vascular Endovascular Repair Summit
MicroPort® Celebrates its 20th Anniversary
Firebird2® Gains Regulatory Approval in Taiwan
Columbus® Proved Cost-effective by Health Economic Evaluation Report
MicroPort® Attends OCC 2018
MicroPort® Awarded as "Shanghai Brand"
MicroPort® Attends CCIF 2018
MicroPort® Attends Exposition on China Indigenous Brand
MicroPort® EP Obtains CFDA Approval for Columbus® 3D EP Navigation System (2.0)
MicroPort® Attends SCC 2018
First Implantation of Rega™ Family Implantable Pacemakers in China
MicroPort® Displays Firehawk® in EuroPCR
MicroPort® Hosts the Investigator Meeting for Firehawk® TARGET DAPT Trial
MicroPort® CRM Holds the 12th Edition of New Horizons Scientific Conference
MicroPort Hosts "Firehawk Challenging Hub-Meet the Best" Event in TCTAP
MicroPort® CRM Announces PMDA Approval in Japan of PLATINIUM™ 4LV SonR®CRT-D PLATINIUM™ 4LV SonR* combines quadripolar IS-4 left ventricular pacing options with SonR
MicroPort's® Firehawk® Drug Eluting Stent Achieves Primary Endpoint and Shows Very Promising Results From TARGET All-Comers Clinical Trial
MicroPort® Attends CIT 2018
CIT 2018: MicroPort® Hosts Twilight Symposium "MicroPort® 20 Years – From Firehawk® to Firesorb®"
Foreign Experts Visit MicroPort® During CIT 2018
MicroPort® Orthopedics Attends 2018 Qinling Joint Surgery Master Forum
MicroPort® Orthopedics Holds China-Australia Medial Pivot Knee Seminar
MicroPort® NeuroTech Attends 15th CFCVD
MicroPort® CardioFlow Attends Fourth China Valve (Hangzhou) Meeting
MicroPort® CardioFlow Releases One-year Clinical Outcome of VitaFlow®
Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC
MicroPort® Completes the Acquisition of the Cardiac Rhythm Management Business from LivaNova
MicroPort® Announces Shareholder Approval for the Acquisition of the Cardiac Rhythm Management Business from LivaNova
MicroPort® EP Attends the 10th VAS-CHINA
Foxtrot™ NC PTCA Gains Regulatory Approval in Malaysia
Firehawk® Gains Regulatory Approval in Myanmar
MicroPort® Scientific India Attends Annual Arthroplasty Conference Hyderabad
MicroPort® Attends MD&M WEST 2018
MicroPort® Single-channel ECG Recorder Becomes the First Product Approved According to the Registration Policy
MicroPort® Orthopedics Attends CHS 2018
MicroPort® Attends INDIA LIVE 2018
MicroPort® Vertebral Artery Rapamycin Target Eluting Stent System Granted CFDA Green-Path
MPSC Announces 2017 Annual Results
Tubridge® Gains CFDA Approval
Study Shows Patients with MicroPort's® Medial-Pivot Knee Are More Likely to Forget They've Had a Joint Replacement (MicroPort's® medial-pivot knee was designed to provide more stability and replicate the natural kinematics of the...
MicroPort® Signs Strategic Agreement with Wuhan Asian Industrial
MicroPort® Signs Strategic Agreement with Neptunus Biotechnology
MicroPort® EP Attends 2018 Dunhuang Cardiovascular Disease Forum to Display Columbus™
Firehawk® Gains Regulatory Approval in Taiwan
MicroPort® Attends the CCC2018
MicroPort® Visits Baxiakeqi Village in Xinjiang for Charity Donation
SuperPath™ Technique Helps 103-Year-Old Stand on His Feet the Same Day after Surgery
Firefighter™, Foxtrot® Pro, and Foxtrot® NC Gain Regulatory Approval in India
MicroPort® Gains its Fifth State Science and Technology Progress Award
MSC Hosts Product Launch of Rega™ Family Implantable Pacemakers
MicroPort® Awarded "2017 China Intellectual Property Model Enterprise"
MicroPort® Awarded "Shanghai Top Brand"
MicroPort® Awarded 2017 Shanghai Pilot Enterprise with Outstanding Innovation
MicroPort® Selected as "2017 China Innovative Medical Device Company"
MicroPort® Orthopedics Holds the Third TKA Training Course in Hong Kong
MicroPort® NeuroTech Attends CINS 2017
MicroPort® CardioFlow Attends 2017 PCR-CIT China Chengdu Valves
Dongguan Kewei Attends 17th National Thoracic and Cardiovascular Surgery Congress
MicroPort® Lifesciences Attends CDS2017
MicroPort® EP's RhythmWatch™ Single Lead ECG Recorder Gains CFDA (Class II) Approval
MicroPort® Attends CBS 2017
MicroPort® Orthopedics Invites Professor David Blaha for Academic Exchange
MicroPort® Orthopedics Attends 12th COA
MicroPort® EP's Contact Force Sensing RF Ablation Catheter Gains CFDA Green-Path
MicroPort® Attends Ninth Indonesian Society of Interventional Cardiology Annual Meeting
MicroPort® Attends 28th GW-ICC
MicroPort® Hosts Firehawk® SAFE Study Protocol Symposium
WALTZ™ Gains Regulatory Approval in Brazil
MicroPort® NeuroTech Attends 17th OCIN
FOXTROT™ NC PTCA Balloon Catheter Gains Regulatory Approval in Argentina
MicroPort® Attends TCT to Display Firehawk® and Firesorb®
MicroPort® Enters into Binding Letter of Intent to Buy Cardiac Rhythm Management Business Franchise from LivaNova for $190 Million
MicroPort® CardioFlow Attends 2017 PCR London Valves
MicroPort® Angiography Guidewire Obtains CFDA Registration Certificate
MicroPort® Orthopedics Attends Elite Arthroplasty Course-EAC-ISKAA in India
MicroPort® Listed as "2017 China Import & Export High Quality and Credibility Enterprises"
MicroPort® EP Attends 2017 Guangdong Medical Association Cardiology Academic Annual Meeting to Display Columbus™
MicroPort® NeuroTech Donates WILLIS® to an Injured in Jiuzhaigou Earthquake
MicroPort® Hosts Training Course of Medical Device Inspector Training Base
MSC CompassAnalyzer™ PSA Completes Patient Enrollment
The First Case of Firehawk® in Kazakhstan Completed
First Case of Firehawk® in Tibet Completed
MicroPort® Hosts Supply Chain Innovation Summit
MicroPort® Orthopedics Hosts SuperPath™ Hip Arthroplasty and Fast Recovery Seminar
Canadian Orthopedic Expert Professor Paul Beaule Visits MicroPort® Orthopedics for Academic Exchange
MicroPort® Orthopedics Holds Medial Pivot Knee Roadshow
MicroPort® Orthopedics Hosts 2017 Asia Pacific Didactic Meeting
MicroPort® Orthopedics Hosts Satellite Meeting in CAS 2017
MicroPort® Hosted the Investigator Meeting for Firehawk® TARGET CTO Trial in Beijing
MicroPort® Firesorb® FUTURE II Trial Completes Enrolling the First Patient
Firefighter™ PTCA Balloon Catheter Receives Regulatory Approval in South Korea
First Domestically Made World-Class Pacemaker Device Gains CFDA Approval
First Scoliosis Surgery of Takin™ Spinal Posterior Fixation System Successfully Completed
MicroPort® and U&I Corporation Signs Cooperation Agreement
MicroPort® CardioFlow Brings in Strategic Investors –China Renaissance, CICC and Huatai Securities
MicroPort® Orthopedics Announces Launch of its Procotyl® Prime Acetabular Cup System for Total Hip Replacement Surgery in US
MicroPort® EP Obtains CFDA Approval for PathBuilder™ Transseptal Guiding Introducer and Needle
First Surgery of Using Takin™ Spinal Posterior Fixation System in the Treatment of Complex Spinal Tumor Successfully Completed
Firefighter™ PTCA Balloon Catheter Gains Regulatory Approval in Argentina
MicroPort® EP Quoted on NEEQ
Firehawk® and Foxtrot Pro® Obtain Regulatory Approval in Malaysia
Firehawk® Displayed in 14th ICSM Annual Conference
MicroPort® Lifesciences Hosts GnRH Pump Treatment Symposium
MicroPort® Attends BIOME Device China 2017
MicroPort® Broadcasts a High-risk Live Case of Firehawk® in SOLACI 2017
MicroPort® Attends 14th Cardiac Imaging & Cardiac Interventional Summit
MicroPort® Orthopedics Holds the Second TKA Training Course in Hong Kong
MicroPort® Awarded
MicroPort® Orthopedics Signs Strategic Agreement with Wiltrom Medical
MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261%
MicroPort® EP Receives Approval to be Quoted on NEEQ
MicroPort® Lifesciences Attends 2017 CEA Annual Meeting
MSC Launches Clinical Trial for CompassAnalyzer™ PSA
MicroPort® and Shanghai East Hospital Establish Translational Medicine Joint Research Center
MicroPort® EP Attends EUROPACE-CARDIOSTIM 2017
Firefighter™ PTCA Balloon Catheter Gains CFDA Approval
MicroPort® Orthopedics Hosts US-Chinese Surgeons Academic Exchange Program
MicroPort® EP Participates in a Free Clinic in Jiangxi
MicroPort® EP Attends CSA 2017
MPSC Signs Investment Agreement with Zenomics to Promote the Translation of "Smart" Insulin Devices
MPSC 2017 Annual General Meeting Held
MicroPort® OrthoRecon Attends the 5th Chinese Knee Society Conference
MicroPort® EP Obtains CFDA Approval for OptimAblate™ Irrigation Pump
MicroPort® OrthoRecon Hosts Hip Replacement Live Surgery Symposium
MPSC New COO Glendy Wang on Board
MicroPort® NeuroTech Attends CSIR 2017
MicroPort® Attends China and CEEC Health Economy Conference and Exhibition
Firefighter™ PTCA Balloon Dilatation Catheter Gains Regulatory Approval in Brazil
MicroPort® Co-organizes Training Program of 2017 Coronary Interventional Treatment Training Center – Shanghai Division
MicroPort® NeuroTech Attends CSA & TISC 2017
The Project "Research on a Minimal Invasive, High Efficiency Orthopedic Robotic System" Officially Launched in Shanghai
MicroPort® Attends OCC 2017
MicroPort® OrthoRecon Project Listed in National Key R&D Plan
MicroPort® OrthoRecon Hosts SuperPath™ Training Course
MicroPort® EP's Project "Cardiac Telemedicine System Based on Smart Device and Cloud" Wins 2016 Shanghai Internet of Things Innovative Product Award
MicroPort® Hosts 2017 Coronary Product Distributor Conference
ARBORES™ Kyphoplastic Balloon Catheter Receives CE Mark Approval
MicroPort® OrthoRecon Attends CAOS 2017
MicroPort® Celebrates its 19th Anniversary
Dongguan Kewei Hosts 2017 EverMend Structural Heart Disease Expert Salon
First Patient Enrolled for Firehawk® Malaysian TARGET MR Clinical Trial
MicroPort® EP Obtains Thailand FDA Approval for Four Products
MicroPort® Listed as Enterprises Conforming to CSR Standards for Six Consecutive Years
CFDA Official Fanpu Kong Visits MicroPort®
MicroPort® Firehawk® Shows Promising Three-month OCT Results from TARGET All Comers Trial
MicroPort® Broadcasts a Live Case of Firesorb® in EuroPCR
MicroPort® Broadcasted Two Complex Operations with Firehawk® in EuroPCR 2017
MicroPort® Releases the Latest Clinical Data of TARGET Series Studies
MicroPort® Attends CCIF 2017
MicroPort® NeuroTech Wins the First Prize in "Product R&D and Achievement Transformation" Group of CIAP Innovation Competition
The Article of "Experience with the Columbus™ 3D EP Navigation System in the Dominican Republic" Published in Cardiac Rhythm News
FireMagic™ 3D Gains CFDA Approval
MicroPort® OrthoRecon Attends the Sixth Jiangsu Zhejiang Shanghai Anhui Joint Summit
MicroPort® Attends SCC 2017
MicroPort® Attends Annual Meeting of NIC
CFDA Official Zhexiong Wang Visits MicroPort®
MicroPort® Awarded Shanghai Pudong New Area Top 20 Outstanding Contributor to Advanced Manufacturing Industry
Two MicroPort® EP Products Counted in Ten Innovative Medical Devices Gaining CFDA Approval in 2016
MicroPort® Signs Strategic Partnership Agreement with China Medical Instrument
MicroPort® Attends CIT 2017 and Releases One-year Clinical and Angiographic Results of Firesorb® FUTURE I Trial
MicroPort® Signs MOU with Ministry of Health of Malaysia Initiating Firehawk® TARGET MALAYSIA REGISTRY
Three MicroPort® Products Included in the List of the Third Batch of Excellent Domestically Made Medical Products
Firehawk® Obtains Regulatory Approval in Colombia
MicroPort® Signs Strategic Partnership Agreement with Shanghai Pharmaceuticals Medical Device
MicroPort® EP Flashpoint™ Renal Artery RF Ablation Catheter Gains CFDA Green-Path
MicroPort® Orthopedics Announces Launch of its EVOLUTION® Revision Tibial System and EVOLUTION® BioFoam® Tibia in US and Europe
MicroPort® OrthoRecon Attends 5th CHS Annual Meeting
MPSC Launches Firehawk® in Press Conference and INDIA LIVE
MicroPort® NeuroTech Hosts WILLIS® Academic Symposium
MicroPort® EP Attends the 14th International Conference on Cardiac Electrophysiology
MicroPort® Hosts the Investigator Meeting for Firesorb® Pivotal Clinical Study - FUTURE II Trial
MPSC Selected as Shenzhen-Hong Kong Stock Connect Eligible Stock
FireMagic™ Cardiac RF Ablation Catheter and EasyFinder™ Fixed Curve Diagnostic Catheter Gain MFDS Approval
MicroPort® OrthoRecon Launches Medial-Pivot Knee Postmarket Clinical Follow-up Program
Firehawk® Receives Regulatory Approval in Mexico
MicroPort® Attends AsiaPCR 2017
Three Products of MicroPort® Included in 2016 Shanghai Innovative Product Recommendation List
MicroPort® Attends MD&M WEST 2017
MicroPort® Holds Two Coronary Artery CTO Workshops in Malaysia
MicroPort® EP Attends the 9th VAS-CHINA
MicroPort® OrthoRecon Attends 2nd National Academic Conference in Enhanced Recovery After Arthroplasty
Firehawk® Displayed in 2017 Pakistan Live
MicroPort® Attends CADECI and Completes First Firehawk® Implantation in Mexico
MicroPort Orthopedics Inc. Announces Results of Clinical Outcome Study Demonstrating 98.8% Implant Survivorship of its Medial-Pivot Knee System at 17 Years <br>- High Overall Patient Satisfaction, Pain Relief and Functional Recovery Also Reported -
FOXTROT® NC PTCA Balloon Catheter Gains Regulatory Approval in Mexico
First Implantation of Firehawk® in India Completed
MSC Attends 2017 International Cardiac Pacing Conference
MicroPort® Receives CFDA Approval for APOLLO Intracranial Stent System in Large Sizes
Firehawk® Receives Regulatory Approval in South Korea
Firesorb® Displayed in Taiwan Transcatheter Therapeutics 2017
MicroPort® Re-awarded Shanghai Five-Star Credit Enterprise
Dongguan Kewei Wins the Second Prize of State Science and Technology Progress Award for the Project "New Technology and Clinical Application of Minimally Invasive Cardiac Surgery"
MicroPort® Attends 19th Annual Meeting of CHEA
First Indian Rate Contract Kicks Off in 2017
First Evolution™ Total Knee Replacement Completed in Heilongjiang Province
MicroPort® Staffs Participate in Voluntary Blood Donation
MicroPort® Awarded "2016 National Model Academicians and Experts Workstation"
MicroPort® Orthopedics Holds TKA Training Course in Hong Kong
MicroPort® Holds First Roadshow for its Incubator Project
MicroPort® was selected as a pilot project of Patent Alliance of Enterprises in Shanghai Zhangjiang National Innovation Demonstration Zone
MicroPort® Orthopedics Completes First Evolution™ Total Knee Replacement in Jinhua City
MicroPort® Completes Patient Enrollment of VitaFlow™ Pre-market Clinical Trial
MicroPort® NeuroTech Attends CINS 2016
MicroPort® Attends CBS2016
MicroPort® EP Attends Dunhuang Cardiovascular Disease Forum
MSC Receives the Second Prize in Biomedical Industry Group of Fifth China Innovation & Entrepreneurship Competition
MicroPort® Attends Symposium on China-Africa Partnership in Improving Access to Health and Medical Products
Delegation of Malawi Ministry of Health Visits MicroPort®
MicroPort® NeuroTech Attends 2016 CCVF
MicroPort® Announces a Strategic Partnership with MinInvasive in the Shoulder Rotator Cuff Repair Sports Medicine Market for China
MicroPort® Orthopedics Attends 11th International Congress of COA
MicroPort® Firesorb® and Firehawk® Star in TCT 2016
MicroPort® Holds the 7th Sports Meeting
MicroPort® Holds 2016 Efficiency Meeting
MicroPort® Listed Among "2016 National Technology Innovation Model Enterprises"
MicroPort® OrthoRecon Attends the 36th Annual Congress of HKOA
MicroPort® Hosts 2016 Technical Innovation and Interactive Suppliers Congress
Experts of Chinese Society of Biotechnology Visit MicroPort®
MicroPort® NeuroTech Attends OCIN 2016
MicroPort® Wins Annual PMO Award of PMI (China)
Dongguan Kewei Recognized as &quot;Company with Patent Advantage&quot; in 2016 by Local Government
Dongguan Kewei Attends First Annual Meeting of China Extracorporeal Life Support Association
MicroPort® Concludes Enrollment In Randomized, Multicenter, European Study Of Firehawk® Coronary Stent System
First Firehawk® Implantation in Pakistan Completed
MicroPort® EP Attends APHRS 2016
MicroPort® Attends GW-ICC 2016
MicroPort® EP Attends 2016 Academic Annual Meeting of the Cardiology Society of Guangdong Medical Association to Display Columbus®
FireMagic® Cool Catheter Obtains CFDA Approval
Firehawk® Receives South Korea KGMP Certification
MSC Displays Innovative Devices at 2016 Innovation Week Expo
MicroPort® EP and MSC Attend 12th Biennial Congress of Chinese Society of Pacing and Electrophysiology
MSC Receives &quot;Best Investment Value Award&quot; in 2016 &quot;Startup Shanghai&quot; Innovation &amp; Entrepreneurship Competition
MicroPort® OrthoRecon Hosts Second SuperPath™ Online Debate
MicroPort® Hosts First EMEA Regional Distributor Summit
MicroPort® Receives "Best Sportsmanship Award" of 2016 "Zhangjiang Cup" Dragon Boat Race
MicroPort® OrthoRecon Launches the First Course of Integrity in Motion – TKA Surgical Technique with Medial Pivot Knee Application Series
MicroPort® OrthoRecon Hosts Satellite Meeting in CAS2016
State Council Counselor Xianping Xu Visits MicroPort®
MPO Signs Agreement with American Sports Celebrity Terry Bradshaw to Endorse Evolution™ Knee
Firehawk® Receives Regulatory Approval in Pakistan
MicroPort® EP Attends First Central and Western China Heart Rhythm Forum
MicroPort® EP Attends 5th Longcheng Cardiology Conference
First Firehawk® Implantation in East Europe Completed
VitaFlow™ Granted CFDA Green-Path
MicroPort® OrthoRecon Participates in 2016 China MIS Joint Replacement and Fast Recovery Academic Conference
Indian Subsidiary of MicroPort® Scientific Established
Innovation, Translation, and Cooperation: MicroPort® Attends CHC 2016 to Present Firehawk®
Firehawk® Receives Approval from Vietnam's Ministry of Health
MicroPort® Receives Interview from Pakistan Television Corporation
Dongguan Kewei Hosts the Second Extracorporeal Circulation Story-sharing Session in National Meeting of Extra-Corporeal Circulation
MicroPort® Hosts the Opening Ceremony of the 7th Aorta intervention International Forum
MicroPort® Catheter Sheath Group Products Obtains CFDA Registration Certificate
Firehawk® Approved for Market Launch in Argentina
MPSC Announces Profit Turnaround in 1H 2016
Firefighter™ PTCA Balloon Dilatation Catheter Granted CE Mark
Firehawk® Granted Market Approval in India
MicroPort® Lifesciences Hosts Satellite Meeting in 2016 Annual Academic Meeting of Society of Diabetology & Society of Endocrinology of Guangxi Medical Association
WILLIS® Granted Market Approval in Thailand
Dongguan Kewei's Polypropylene Hernia Mesh Granted CFDA Approval
MPSC 2016 Annual General Meeting Held
MicroPort® Attends SOLACI 2016
Firehawk® Approved for Market Launch in Brazil
MicroPort® Attends OCC 2016
Firehawk® Gains CFDA Approval to Extend Shelf Life to Two Years
Firesorb™ Granted Green Channel Status for CFDA Approval
FireMagic® Obtains CFDA Registration Certificate
MicroPort® Hosts Scientific Lectures on Frontier Exploration of Universe
MSC Completes First Implantation in FIM Clinical Trial of "Made-in-Shanghai" BonaFire® Pacing Lead
Colombian Consult General in Shanghai Visits MicroPort®
MicroPort® OrthoRecon Hosts SuperPath™ Satellite Meeting in CHJS Annual Meeting
MicroPort® Releases Updates of its Cardiovascular Devices in EuroPCR 2016
Single Use Cardioplegia Delivery System Obtains CE Mark
WILLIS® Included in Shanghai's Drug Reimbursement List
MicroPort® Asia-Pacific Knee Arthroplasty Training Center Established in Shanghai
MicroPort® Introduces its Transcatheter Aortic Valve in China Valve
MicroPort® Attends the 18th SCC 2016
MicroPort® EP Makes the First Live Broadcasting of Columbus® Surgery
MicroPort® Arthroplasty Technique Training Center Launched in the Second Affiliated Hospital of Xi'an Jiaotong University
First Use of Evermend™ Occluder in Shymkent of Kazakhstan
First-in-Man Clinical Trials of Firesorb™ Completes Patient Enrollment
MicroPort® Online "Life Line Live" Officially Launched
MicroPort® Joint Launches "Fast Recovery" Training Course and MicroPort® Arthroplasty Training Center
MicroPort® and Yizheng Municipal Government Establishes "Shanghai-Yizheng Healthcare Cooperation Project"
MicroPort® Attends CIT 2016
MicroPort® Signs Cooperation Agreement with Beijing Weimai Medical Device
Columbus® Granted CFDA Registration Certificate
MicroPort® EP Attends 13th IDSS
FOXTROT™ PRO Gains Market Approval in Indonesia
MicroPort® EP Attends the 8th Atrial Fibrillation Key Technology International Forum
MicroPort® Awarded Five Star Credit Enterprise
Tubridge™ Granted Green Channel Status for CFDA Approval
MicroPort® Orthopedics Donates Hip Prosthesis in a Charitable SuperPath™ Surgery
MicroPort® Attends AsiaPCR 2016
MicroPort® Firesorb Bioresorbable Rapamycin Target Eluting Coronary Scaffold System Completes First Successful Implantation in the First FIM Clinical Trial
Dongguan Kewei Disposable Arterial Micro Plug Filter Obtains EU CE Certification
Disposable Intravascular Catheter Accessories Product Obtains CFDA Certification
MicroPort® Science and Technology Innovation Platform Won the State Science and Technology Progress Award
MicroPort® D-Pulse Product Obtained CFDA Registration Certificate
Product of MicroPort® EP Completed First Clinical Case Observation
MicroPort® EP OptimAblate™ Cardiac RF Generator and OptimAblate™ Irrigation Pump Obtained CE Certification of EU
Registration of Dongguan Kewei Occluder Series Products in Kazakhstan Approved
MicroPort® Completed the First Distant Interactive Surgery in the Field of Coronary Interventional Treatment
First Patient Enrolled in MicroPort's TARGET All Comer Clinical Trial, a Multi-center, Prospective, Randomized, Controlled, European Clinical Study for the Firehawk Rapamycin Target Eluting Coronary Stent System
MicroPort® EP Columbus™ System Attends 2015 Dunhuang EP Tutorial Conference
The Registration has been Approved in Italy and South Africa for Reindeer™ Locking Compression Plate System
Firehawk® Indonesia's Market-entry Meeting
MicroPort® Orthopedics Attend the Tenth Session of the COA International Conference
MicroPort® Invited Chinese Experts to Attend the Pakistan Cardiology Academic Conference for the First Time
MicroPort® NeuroTech Generous Donation
MicroPort® Orthopedics Invited Professor Jimmy Chow Come to China to Carry Out SuperPath™ Academic Exchange Activities
The Registration has been approved in Philippines for WALTZ™ Cobalt Alloy Stent System
MicroPort® Joint participated in the 35th Annual Orthopedics Conference of Hongkong
Kai Ma, Member of The Political Bureau of the CPC Central Committee, vice premier of the State Council, came to visit MPSC
First Procedure of MicroPort® Orthopedics Firestone™ Cervical Fusion Device Successfully Completed
MicroPort® Attends TCT 2015
EasyFinder™ Electrophysiology Steerable Diagnostic Catheter Gains CFDA Approval
MicroPort® Attends the Ninth Oriental Cardiology Meeting
MicroPort Scientific Corporation Announce Leadership Changes in MicroPort Orthopedics Subsidiary and Membership Changes in CEC, IEC
MicroPort® Lifesciences Attends the Fourteenth National Endocrinology Conference of Chinese Medical Association
MPSC New COO Appointment – Jason Zhang
Fast Recovery - The New Concept of Medical Science for Joint Replacement
MicroPort Orthopedics Launches Profemur™ Preserve™ Hip Stem Inaugural Surgery Performed by Phillip Merritt, MD
FOXTROT™ PTCA Balloon Catheter Gains CFDA Approval
MicroPort® Attends CHC 2015
MicroPort® Attends SOLACI 2015
New Technology Clinical Study of Second Generation Bioresorbable Scaffold System Completed
FOXTROT™ PRO PTCA Gains Market Approval in Thailand
MicroPort® Orthopedics Completes First Implantation of Futago™
MicroPort EP Attends CAFS to Promote Columbus™
MicroPort® Lifesciences Attends Diabetes and Gonadal Disorders Meeting to Promote La Fenice®
MicroPort® Orthopedics Femoral Head Biolox Delta Ceramic and Rim-Lock Biolox Delta Ceramic Liner Awarded CFDA Registration Certificate
Evolution™ Gains CFDA Registration Certificate
MicroPort® NeuroTech Attends CSA&TISC to Promote APOLLO
MPSC Annual General Meeting Held
MicroPort Sorin CRM Launches China's First Domestic Pacemaker Production Line
Tubridge™: The Breakthrough Aneurism Medical Device
MicroPort Attends EuroPCR 2015
VSD Occluder Gains CFDA Registration Certificate
MicroPort Hosts 2015 Annual Distributor Conference
Shanghai MicroPort Orthopedics Hosts First SuperPath™ Online Symposium
Firehawk® and WILLIS® Proved Cost-effective
Shanghai MicroPort Orthopedics Attends World Arthroplasty Congress
FOXTROT PRO PTCA Balloon Dilatation Catheter Awarded CE Mark
MicroPort Attends CIT 2015
FOXTROT™ NC PTCA Balloon Catheter Gains FDA Approval
Futago™ Lumbar & Thoracic Fusion Device Awarded CFDA Registration Certificate
PROFEMUR™ Classic TL Hip Stem Awarded CFDA Registration Certificate
Angiographic Catheter Awarded Registration Certificate
MicroPort Orthopedics Counted Among "10 to Watch" By The Greater Memphis Chamber
Evolution™ Launched in Hong Kong
MicroPort Receives CE Mark Approval for Firehawk® To Commence Commercialization of Firehawk® in the European market
Firehawk® Clinical Results
Mr. Aurelio Sahagun Promoted to COO of MicroPort Orthopedics
PROPHECY® Registered with CFDA for Record
Research Project of WILLIS® Clinical Application Granted Award
La Fenice® Insulin Pump Awarded Re-registration Certificate
Firehawk® Gains CFDA Approval to Offer More Specifications
MicroPort Orthopedics Reaches Fast Recovery® Milestone with 1,000 SuperPath® Hip Procedures
MicroPort Completes the First Bilateral SuperPath™ THA in China
MicroPort Establishes Translational Medicine Joint Research Center with Second Military Medical University
MPSC New CHRO on Board
MicroPort Orthopedics Attends the Ninth COA Congress
MicroPort Promotes Awareness of Heart Attack in Beijing Community
PROFEMUR® Classic Z Hip Stem Awarded CFDA Registration Certificate
MicroPort NeuroTech Attends OCIN
La Fenice® Awarded High-tech Project
D-Pulse Gains CE Certificate for PCI Surgical Accessories
MicroPort Completes First Human Implantation of its Transcatheter Aortic Valve
MicroPort Promotes Firehawk® in TCT 2014
ADVANCE® Knee System Awarded Registration in China
First Use of SUPERPATH® in East China
MicroPort Orthopedics Shanghai Held Academic Symposium
MicroPort Attends CHC to Promote Firehawk
Learn to love back
MicroPort Orthopedics & MB Innovations Announce Partnership
MicroPort Annual General Meeting Held
MicroPort Promoting Awareness of Heart Attack
MicroPort Promotes Firehawk in OCC
MicroPort Hosts Symposium on Firehawk During EuroPCR 2014
Government Authorities Approve Joint Venture for Cardiac Rhythm Management Business In China
WILLIS Granted “Shanghai Innovative Product”
MicroPort Celebrates 16th Anniversary and Headquarter Relocation
MicroPort Receives Investment From GIC
MicroPort Released New Products to its Nationwide Distributors
Report From China Interventional Therapeutics Conference
"微创" and "MicroPort" were recognized as "China's National Well-known Trademark"
Reindeer™ Metal Locking Plate System Approved by CFDA
WALTZ Gain CE Certificate
Firehawk® Rapamycin Target Eluting Coronary Stent was approved by CFDA
MicroPort Scientific Completes Acquisition of Wright Medical's OrthoRecon Business
Shanghai MicroPort EP MedTech Completed the First Multi-electrode Ablation Case in the Clinical Trial of FlashPoint™ Renal Artery RF Ablation System
MicroPort Scientific Corporation and Sorin Group Sign Joint Venture Agreement for Cardiac Rhythm Management Business in China
Shanghai MicroPort EP MedTech Announces First Case of the Clinical Trial Of FlashPoint&trade; Renal Artery RF Ablation System
Appointment of Non-executive Director and Member of Nomination Committee
MicroPort Received CE Approval for FireMagic™, EasyFinder™, EasyLoop™ and FireMagic™ 3D
MicroPort Received CFDA Approval for Newly Extended Specifications of Apollo Intracranial Arterial Stent System
MicroPort Received Re-registration for GnRH Infusion Pump
MicroPort Foxtrot PTCA Balloon Dilatation Catheter Received CE Certificate
Columbus&trade; Three-dimensional EP Navigation System Received CE Certificate
MicroPort Pioneer Balloon Dilatation Catheter Received CFDA Re-registration Certificate
Multi-Center Clinical Study Result-Summary Meeting of Tubridge and Microcatheter Held in Shanghai
Zunyi MicroPort Hope Primary School Completed
The Annual General Meeting of MicroPort Scientific Corporation 2013 Held in Shanghai
MicroPort Scientific Corporation and Wright Medical Group, Inc. Enter Into Definitive Agreement Under Which MicroPort Will Acquire Wright's OrthoRecon Business
Disposable Cervical Dilator Received SFDA Product Certificate
Former Minister of Health Visited MicroPort
MicroPort Presented at EuroPCR 2013
MicroPort Orthopedic Suzhou Industrial Base Started Construction
2nd Shanghai Emerging MediTech Symposium Held in Shanghai
Fireforce Balloon Inflation Device Received Product Certificate from Thailand
"Wealth-Sharing Opportunity, Win-Win Cooperation"--2013 MicroPort Distributor Conference Held in Shanghai
First Secretary of Central Committee Party Visiting MicroPort
MicroPort Published 2012 Annual Result
Two Occluder Devices Received SFDA Re-registrations
Dr. Martin B. Leon Visiting MicroPort
Cooperation, Innovation and Transition: The New Focus of CIT and MicroPort
Radial Artery Hemostasis Set Received Re-registration Certificate
WILLIS® Intracranial Stent Graft System Received SFDA Approval
Insulin Pump Infusion Set Received Re-registration Certificate
&laquo;Eyes for Greatness, Hands on Details&raquo;<br> 2013 MicroPort Annual Employee Meeting and Award Ceremony Grandly Held
The Company Hold its 55th MicroPort Biomedical Forum in Shanghai
CCC2013 and CISC Convened in Beijing
MicroPort's Building Innovation Capability Project of State Accredited Enterprise Technical Centers approved
MicroPort NeuroTech Officially Opened
MicroPort Hold its First Medical Equipment Quality Forum in Shanghai
Patent of MicroPort Won China Patent Honorable Mention
MicroPort awarded "TOP 10 ENTERPRISE PRIZE"
The 53rd MicroPort Biomedical Forum
Three First-tier Instrument Sets of Suzhou Health First Received SFDA Approval
Happiness Begins From Heart - MicroPort Heart Journey patient education serial lectures
Humble Stent, Prosperous Future
Tubridge Parent Artery Reconstruction Device Initiated Clinical Trial
Dr. Martin B. Leon Announced the Latest TARGET I Randomized Controlled Trial Data to the World
Mustang&#8482; Coronary Stent System Re-registered Successfully by SFDA
Four MicroPort Programs Selected as 2012 National Key Technology R&D Program for the 12th Five-year Plan
The Latest TARGET I Randomized Controlled Trial Data Announced for MicroPort's Firehawk
2012 Best Customer Service Awarded to MicroPort Lifesciences Shanghai
MicroPort Medical (Shanghai) Co., Ltd. Renamed Shanghai MicroPort Medical (Group)Co.,Ltd. Officially
MicroPort HR Team Awarded as the 2012 Outstanding HR Management Team in Medical Industry
MicroPort Firebird 2 Registered Successfully in Uruguay
MicroPort La Fenice® GnRH Infusion Pump Brought Light to Sterility Patients
China Heart Congress 2012 Held in Beijing
The Journey of WE Talk
MicroPort Firebird 2 Successfully Registered in Ecuador
Project of Strategic Innovation Alliance of Minimally Invasive and Implanted Medical Devices Technology Accepted
The 10th China Atrial Fibrillation Symposium Held in Dalian
MicroPort New-Power Summer Camp 2012 Initiated
Appointment and Resignation of Top Management
52nd MicroPort Biomedical Forum was Held in Shanghai
MicroPort Established a Wholly-Owned Subsidiary in Shanghai
One-Year Follow-Up Result of TARGET I Clinical Endpoint Appraisal Committee Conference Held in Beijing
Suzhou Health Medical Obtained Business Operating License
The Party General Branch of MicroPort Recognized as Shanghai Outstanding Grass-roots Party
The Annual General Meeting of MicroPort Scientific Corporation 2012 Successfully Held
MicroPort Announced Acquisition of Dongguan Kewei Medical Instrument
The 51 MicroPort Biomedical Forum Held in Shanghai
The Medical Device Industry Development and Investment CEO Summit 2012 Successfully Held in Shanghai
MicroPort Obtained SHFDA Approval for Firepower&#8482; Y-type Connector Suit
The Oriental Congress of Cardiology 2012 Held in Shanghai
Clinical Application Research of WILLIS® Obtained the First Class Award in Science and Technology Progress
The 50th MicroPort Biomedical Forum Held in Shanghai
Euro PCR 2012
MicroPort Employee Appreciation & Recognition Day and Celebration of Company 14th Anniversary
The 13th Leadership Exchanging Meeting of SFIC Held Successfully
MicroPort Received 2012 National Labor Award
Mustang® and JIVE PTCA Registered Successfully in Vietnam
MicroPort Orthopedics Receives FDA 510k Approval for Reindeer&#8482; Locking Plate System
MicroPort Established Aspiration Scholarship for Shanghai Jiao Tong University
EasyLoop&#8482; Diagnostic Catheter Approved by SFDA
MicroPort Receives SFDA Approval for GnRH Infusion Pump
PuJiang EmergingMedical Technology Forum 2012 Successfully Held in Shanghai
Feeling Firehawk, Targeting Future <br>Announcement of Results in Firehawk FIM and TARGET I Long Stent Group Research Study
Patient Enrollment for TARGET II achieves completion
MicroPort Orthopedics Product got CE certificate once again
MicroPort Insulin Pump Devices Registered Successfully
Three Projects of MicroPort Selected in the 2011 Science & Technology Innovation Plan by STCSM
Dr. Sun Yiyong Enrolled into the Shanghai 2011 Leading Talent Program
MicroPort Orthopedics Wins Two Grants for its Scientific Research Projects
MicroPort Announced Acquisition of Suzhou BEST Orthopedics Corporation
FIREHAWK, safety and effectiveness approved by early clinical studies
Aether Distal Protective Device Successfully Registered in Brazil
The Clinical Result of Micro Pulse Infusion Pumps Published
MicroPort Orthopedic Products Approved for Marketing
MicroPort Distributor Meeting
The 30-Day Follow-Up Result of FIRE2-DIABETES
Shanghai MicroPort Lifesciences Co., Ltd., won the Outstanding Customer Service Award at The China Best Call Center and BPO Summit 2011
Academicians of Chinese Academy of Engineering Visited MicroPort
Trademark Information
The Clinical Trial TARGET II Launched
Columbus&#8482; and Voyager&#8482; Unveiled in the 9th China Atrial Fibrillation Symposium (CAFS)
MicroPort Orthopedic Products Received First International Order
The Patient Enrollment in FIRE2 – DIABETES Clinical Trial Completed
MicroPort Completed FIM for Two EP Products
The Randomized Controlled Clinical Trial of Firebird2 Launched
Shanghai MicroPort EP MedTech Co., Ltd. Participated in the 15th Forum of China Heart Rhythm Society
MicroPort Awarded as One of the Top 10 China Intellectual Property Brand Names of the Year
Trademark and Patent Issuing Information
Professor Chang's visit to the 48th MicroPort Forum
Medical Device Committee of Shanghai Pudong Bio Industry Association Established
La Fenice Registered with the Chinese Trademark Office
MicroPort Announced 12-Month Follow-Up Result of FOCUS
MicroPort Employee Appreciation & Recognition Day and Celebration of Company's 13th Anniversary
MicroPort Established a Wholly Owned Subsidiary in Jiaxing (Zhejiang Province)
The Latest Clinical Research Result of MicroPort's DES
MicroPort Being Issued Two More Invention Patents
MicroPort Recognized as One of the "Shanghai Best Known Trademark"
MicroPort Awarded as "2010 Shanghai Equipment Manufacturing and High-Tech Innovation Brand"
New Start, New Height, New Mindset<br>2011 MicroPort Annual Employee Meeting Held Ceremoniously
MicroPort Completed FIM for Two EP Products
MicroPort Obtained CE Certificates for Four Orthopedics Products
Notice on Centralized Purchasing of High Value Medical Supplies (forwarded from MOH)
MicroPort Certificated as the National-Recognized Enterprise Technology Center
EasyFinder&#8482; Diagnostic Catheter Approved by SFDA
Firebird2 Won the Silver Award of China International Industry Fair 2010
MicroPort Selected as One of the Shanghai 2010 Biomedical Commercialization Projects and Honored a Grant
Mr. Bo Peng Joined the Company Executive Committee
The Top Management of Otsuka Visited MicroPort
MicroPort Hope Primary School Opening Ceremony
MicroPort Orthopedics Selected as One of the Shanghai 2010 Biomedical Commercialization Projects and Honored a Grant
MicroPort Donated 100 Sets of Coronary Stent System to the Tibetan Region
MicroPort Lifesciences Won the Award of '2010 China(Asia-Pacific)Best Service Call-Center'
MicroPort's Stent Inspection Team Awarded as '2010 National Quality Trustworthy Team'
MicroPort Test Centre Certificated as CNAS Accredited Laboratory
MicroPort Is Selected as One of the Fourth Batch of National Pilot Innovative Enterprises
Chinese Vice President Xi Jinping Visited MicroPort
MicroPort Scientific Corporation Commenced Trading on HKEx Main Board
MicroPort Hong Kong Public Offering 224 Times Oversubscribed
MicroPort Announces HKEx Main Board Listing Details
The Clinical Trial TARGET I Launched
Rethinking Lower Blood Pressure Goals for Diabetic Patients with Coronary Artery Disease.
'Top Ten' Forecast for Interventional Cardiology
Japan Successfully Developed a Daily Administrating System for Diabetics
MicroPort Orthopedics Announced the First Implantation of Thoracic and Lumbar Fusion Device ---- Futago™
MicroPort at EuroPCR 2010
The Official Launch of Firebird 2 in Philippine at PSCCI
Latino American cardiovascular surgeons' visits
Firebird 2 Launch in Thailand
MicroPort Established Shanghai MicroPort Orthopedics Co., Ltd.
Growth, Recognition, Appreciation, Reward, MicroPort Employee Recognition & Appreciation Day
Firebird 2 Project listed as key new product plan 2008 in Shanghai
Delegation of Stanford University Visited MicroPort
MicroPort Attended the 6th Atrial Fibrillation Symposium (CAFS)
MicroPort Attended MD&M East 2008
The 2nd Oriental Congress of Cardiology Opens
Mustang Coronary Stent Got Approval of its Re-registration
MicroPort Gained the Certificate of Foreign Medical Device Manufacturer from Japanese Minister of Health, Labor and Welfare
Dr. Zhaohua Chang engaged as commissioner of Expert Consultative Committee, Shanghai Municipal Government Office of Overseas Chinese Affairs
Dr. Zhaohua Chang Attended the Symposium for Non-Public Economy Representatives
Gathering in Academic Pageant, building together a bright future of interventional medicine-The China Interventional Therapeutics (CIT) 2008 successfully held
World Interventional Medicine Expert Team Visited MicroPort
Our Company's "MicroPort" trademark was recently named "Shanghai Famous Trademark"
MicroPort Medical Ranked Forbes
Congratulations on MicroPort's G-2 DES Getting SFDA Approval
MicroPort Medical Attended 13th China Heart Rhythm Forum
Dr. Chang Zhaohua elected as SORSA's Vice President
MicroPort Medical Honored by Deloitte Technology Fast 500 Asia Pacific 2007
MicroPort's FireMagic Ablation Catheter Trial Achieved Interim Results
European Patent Office President Alison Brimelow Visited MicroPort
MicroPort Medical Honored as one of Deloitte Top 50 Fast-growing Chinese Hi-Tech Companies
MicroPort's Firebird 2 Stent Showed up in TCT2007

CRM Tech Corner - Pacemakers
Benoit Clinchamps

Our therapy

leadership team 1
PARAD is a dual-chamber discrimination algorithm which discriminates ventricular tachycardia from supraventricular tachycardia or sinus tachycardia...
The Respond CRT system is a unique combination of a cardiac contractility sensor with an advanced optimization algorithm. Continuous measurement of the...
Brady Tachy Overlap (BTO)
BTO offers the possibility to pace the ventricle(s) up to 145 bpm during exercise, and simultaneously, to detect and treat with painless therapy slow ventricular...
Multipoint Pacing
Give every patient a chance to become a responder. The myocardial substrate in CRT patients can show significant electrical heterogeneity. To overcome this, pacing...
Product Performance Reports
At MicroPort CRM, we are committed to constantly delivering innovative medical devices and services that meet customer expectations and are safe, effective and...
Privacy Policy
MicroPort Scientific Corporation (“MicroPort”) respects your privacy rights and we are committed to the responsible use of Personal Data concerning all stakeholders.
Cookie Policy
We use cookies to provide the website and its services, gather information about your usage patterns when you navigate our pages in order to enhance your...
Paul Vodden
Philippe Wanstok
IR Newsletter
MicroPort Lifesciences Co., Ltd. Beijing, has announced the successful registration of “ Reservior of Insulin Pump ” and “Infusion Set of Insulin Pump”, which were...
Presentation Materials
Some information contained in this presentation contains forward-looking statements. These forward-looking statements include, without limitation, those regarding...
2020 Interim Results
2019 Annual Results
2019 Interim Results
2018 Annual Results
2018 Interim Results
2017 Annual Results
2017 Interim Results
2016 Annual Results
2016 Interim Results
2015 Annual Results
2015 Interim Results
2014 Annual Results
2014 Interim Results
2013 Annual Results
2013 Interim Results
2012 Annual Results
Donations and Grants
First Implant of Firehawk® Stent Successfully Completed in Oman
Two MicroPort® EP Diagnostic Catheters Approved in Australia
Multiple MicroPort® EP Catheters and Devices Approved in Uzbekistan
MicroPort® NeuroTech NUMEN Coil Embolization System Approved for Market in China for the treatment of cerebral aneurysms
The answer study | Download
The clinical benefits of SafeR were investigated during the ANSWER study after 3 years follow-up. The ANSWER study proved that SafeR is Safe and effective for all...
Performance PARAD | Download
In the inappropriate shock reduction study, 1 out of 100 patients implanted with a device featuring PARAD received inappropriate shocks over one year...
Respond-CRT trial
The RESPOND-CRT trial successfully met its primary endpoint demonstrating that automatic AV & VV optimization with SonR technology is safe and as effective...
Protect patients with SAM
SAM is a unique Sleep Apnea Monitoring tool which has been validated against the gold standard Apnea Hypopnea Index determined by polysomnography. Download the study.
Sleep Apnea Detection. Arrhythmia Detection
SpiderSAS is a polygraph Holter allowing for both sleep apnea and arrhythmia detection in one single device. Associated with the SyneScope software...
Free up your time for crucial diagnosis
Spiderview® is the uncompromised Holter solution designed to provide flexibility and efficiency to your clinical practice.
Spiderflash | Long duration event recorder
1 or 2 channels. Recording up to 30 days. Extended capability for 24-hour Holter Monitor recording. 12 types of arrhythmias including Atrial Fibrillation...
Agilis Mini
Oscillometric technology. Up to 250 measurements of systolic and diastolic blood pressure. Automatic cuff size recognition. USB type-C connector. Fast analysis...
SafeR Infographic | Download
Offers a full diagnostic data and unique categorization of AVB episodes: Detailed diagnosis of each AV block episode experienced by the patient; Report on the...
SonR Infographic
SonR sensor continuously measures the contractility of the heart allowing for automatic optimization of AV and VV intervals. Optimization is performed on a weekly...
SmartView Connect
An innovative Bluetooth monitoring that enables remote high-level clinical follow-ups. The SmartView Connect provides daily connectivity to the implantable...
BOREA™ | Connected to life’s every beat.
The smart way to drive efficiency – remotely. Programming set-up and follow-up made easy. Adaptive therapy that learns and evolves with the patient...
OTO | Sense in every cc
World's smallest transvenous pacemaker. Fast and Easy follow-up at a click of a button. Automatically activates algorithms at implant. 11.7 years longevity* in 8 cc.
KORA 250 | Minimum Size. Maximum outcome
Kora 250 is designed to improve patient outcome while driving efficiency in practice. A physiologic pacemaker family designed to improve patient outcome while...
KORA 100 | Always one step ahead
Kora 100 provides the first MRI mode that automatically detects an MRI magnetic field – another innovative solution in a pacing system known for small size...
REPLY 200 | The world’s smallest pacemaker
Reply 200 automatically screens patients at risk of severe sleep apnea, featuring a suite of algorithms designed to prevent serious cardiovascular comorbidities.
REPLY | Natural intelligence
Reply DR includes SafeR, the only AV management algorithm proven to be effective and safe for all of your patients with bradycardia. The world’s smallest...
REPLY (for US only)
Physiologic performance with uncompromised size and longevity. The world’s smallest dual-chamber pacemaker designed for maximal device longevity. Comprehensive...
MicroPort® unveils new research at Virtual American Transcatheter Cardiovascular Therapeutics Conference (TCT Connect)
MicroPort MedBot and Robocath Announce Execution of Definitive Agreements for its Vascular Robotics Joint Venture for the China Territory
Smart Touch
Light Weight enhances mobile usage. Modular Design allows versatile adaption in different clinical environments. Bluetooth Connectivity facilitates wireless...
MicroPort® Awarded with National-Level “Quality Benchmark” Award for second consecutive year
Endovastec™ Castor® Stent Debuted at the First eCICE Conference in Brazil
Platinium | Enter a new era of longevity
World's longest lasting defibrillator backed by warranty. Longevity calculations are based on real life pacing conditions. Warranty applies regardless of pacing...
Code of conduct
Firehawk® Stent, Firefighter™ PTCA Balloon Catheter and Two Other MicroPort® Products Approved for Launch in Ecuador
Columbus™ 3D EP Navigation System V3 Approved in China
First Implantation of Endovastec™ Minos® Stent Graft System Completed in Argentina
MicroPort® NeuroTech Named 2020 Shanghai High-tech “Little Giant” Enterprise
MicroPort® Awarded “Best Open Innovator 2020” at the Fifth China Innovation Challenge and the Third Yangtze River Delta International Innovation Challenge Special Tournament
Firehawk® Debuted at Semana SBHCI 2020
MicroPort® RIC MedTech™ Attended CMEF 2020

CRM / Tech Corner copy

CRM Our therapy
Platinium | Enter a new era of longevity
Longevity calculations are based on real life pacing conditions. Warranty applies regardless of pacing conditions and therapy frequency. Up to 21% savings...
MicroPort® Orthopedics launches A Phase II Multicenter Study on Minimally Invasive Hip Arthroplasty of Joint Surgery in Yunnan Province
MicroPort CRM initiates a clinical trial for breakthrough innovative left ventricular lead Axone™
Daylily™ Single-Use Sterile Embryo Transfer Catheter from HorizonMedical™ approved for use in China
MicroPort® holds interim meeting for Firehawk® TARGET SAFE Research Study
speX Support Catheter Obtains NMPA Registration Certificate
MicroPort® NeuroTech NUMEN™ Coil Products Showcased at Shaolin Neurosurgical Conference
Firehawk Liberty™ Rapamycin Target Eluting Coronary Stent System Registration Approved in Korea
MicroPort® NeuroTech Holds Launch Events for NUMEN™ Coil in Guangzhou and Hebei
Endovastec™ Castor™ Branched Aortic Stent-Graft System Enters First Overseas Market
MicroPort MedBot’s Toumai™ Endoscopic Surgical System Completes First Clinical Trial of Robot-Assisted Partial Nephrectomy
First Clinical Implantation of MicroPort® Left Atrial Appendage Occluder Completed in Shanghai Chest Hospital
MicroPort® Organizes “Belt and Road” International PCI Symposium at CIT Online 2020
MicroPort® NeuroTech Bridge® Vertebral Drug-Eluting Stent Approved for Launch in China
Endovastec™ Accredited as “Shanghai Enterprise Technology Center”
MPO China Hosts The 3rd SuperPATH® Super+User (Better Together) Conference
MPO China Attends The 8th Annual Meeting of Chinese Knee Society (CKS 2020) and Holds “20 Years of Medial-pivot Knee System & 10th Anniversary of Evolution®” Satellite Symposium
HorizonMedical™ Selected as “National High-tech Enterprise”
MicroPort® MedBot’s Toumai™ Endoscopic Robot completes first partial nephrectomy through retroperitoneal approach
MicroPort® RIC MedTech™ Attends the 3rd Annual Academic Conference of CARM-CPTA and Holds Thematic Symposium
MicroPort® MedBot’s Toumai™ Endoscopic Surgical System Completes First Robot-Assisted Extraperitoneal Radical Prostatectomy
MicroPort® EP PathBuilderTM IceMagicTM Steerable Introducer Obtains Important NMPA Registration Approval
MicroPort® Wins APQO Global Performance Excellence Awards 2020
MicroPort® Toumai® Endoscopic Robot Combined with Intraoperative Ultrasound Completes Partial Nephrectomy for Completely Endophytic Renal Tumor
Toumai® Endoscopic Robot Completes First Domestic Robot-assisted Single-port Procedure
Endovastec™ Minos® Stent Graft System Completes First Clinical Implantation in Hungary
Endovastec™ Reewarm® PTX Drug Coated Balloon PTA Catheter Receives EU CE Marking Certification
MicroPort® EP “Talents Program” Holds First Theoretical Training to Enhance Arrhythmias Treatment at Primary Hospitals
Horizon Medical™ Ovum Aspiration Needle Registration Approved in Thailand
MPO China First Domestic Bipolar System for Hemiarthroplasty Receives Marketing Approval, Completing the Domestic Primary Arthroplasty Product Line
MicroPort® Orthopedics China establishes the MicroPort® Engineering Institute Suzhou Branch
MicroPort® NeuroTech’s U-track Intracranial Support Catheter System Approved for Marketing in China
Honghu Total Knee Robot System Completes Multicenter Clinical Trial Enrollment Before Market Launch
MicroPort® Wins First Prize of Shanghai Innovative Achievement Award for Modernized Enterprise Management for the Second Consecutive Year
MicroPort® Coronary Balloon Dilatation Catheter (Firefighter™ NC) Receives Registration Approval in Taiwan
MicroPort® Holds a Symposium on Firehawk® Clinical Progress at Taiwan Transcatheter Therapeutics
Firefighter™ and Foxtrot® Pro PTCA Balloon Catheters Approved for Registration in Pakistan
MicroPort® Subsidiary MicroPort CardioFlow goes public on SEHK
MicroPort® EP’s Disposable Intracardiac Mapping Catheter Obtains Registration Certificate from NMPA
Horizon Medical™’s Daylily® Embryo Transfer Catheter Receives Registration Approval in Thailand
MicroPort CRM launches MicroPort Academy CRM, an education website dedicated to Healthcare Professionals and designed by experts in cardiac pacing
First Patient Enrolled in MicroPort's TARGET IV NA Clinical Trial, a Multi-center, Prospective, Randomized, Controlled Clinical Study for the Firehawk Stent System to Obtain Regulatory Approval in the United States, Canada and Japan
MicroPort Orthopedics Announces Launch of HA Coated Collared Hip Stem and Cemented Collared Hip Stem, Expanding its Hip Stem Portfolio
Patient Enrollment Completed for Clinical Trial of Toumai® Endoscopic Robot
MicroPort® EP Obtains Approval for its Medical Consumables and Equipment in Egypt
MicroPort® CRM partners with the start-up bepatient to conduct a clinical research program on Heart Failure patients
Percutaneous Coronary Intervention
Within two decades, MicroPort® has transformed itself from a market follower, into a global leader in the field of Percutaneous Coronary Intervention (PCI)...
Firehawk Rapamycin Target Eluting Coronary Stent System
Fast healing: exceptional fully Strut Coverage Rate at 3 months. Less stent thrombosis, less inflammation. Potential shortened DAPT. Minimized possibility of...
PCI accessories
Angiography syringe. Pressure monitoring tubings. Y-connector pack. Manifold. Inflation device: is used to pressurize and inflate the balloon of the dilating...
Firebird2 | Rapamycin Eluting Coronary CoCr Stent System
CoCr Stent Platform. Reliable durable polymer-Styrene Butylenes Styrene. Uniform sine wave design provides uniform support strength and flexibility...
Firefighter NC | PTCA Balloon Catheter
Low profile to croos and get to the lesion. High dilation force with great balloon strength. Low compliance allows precise dilation. Improved deliverability...
Firehawk Liberty
Thin but stiff outer layer can endure high pressure while having lower shaft profile. Fluorine-contained inner layer minimized wire-catheter friction therefore...
Firefighter | PTCA Balloon Catheter
Ultra low profile: more confident in crossing complex lesions. Kissing balloon technique in 5F guiding catheter. Superior deliverability. Thinner balloon...
Foxtrot NC | PTCA Balloon Catheter
Superior crossability. Soft tapered tip design. Low crossing profile. Minimum deflation time. Unique Hypertube Design. Great trackability and pushability...
Foxtrot Pro
Smooth tapered tip with lower entry profile of 0.017". Advanced balloon material with 20% thickness reduction. Unique "stripe" coating. Best-in-class shaft profile...
Four Firehawk® and Firefighter™ Products Receive Registration Approval in Saudi Arabia
Firehawk®, Foxtrot® Pro and Foxtrot® NC Receive Approval in Bosnia and Herzegovina
Stock chart
We demonstrate the imagination and pioneering spirit that make MicroPort® a leading innovator in our industry. We transform insights into knowledge quickly and....
MicroPort® NeuroTech launches TWINS and NUMEN® in Yunnan
Microport® EP Devices and Accessories Obtain Approval in Australia
MicroPort® Holds Groundbreaking Ceremony for R&D Building in Jiaxing MicroPort® Campus️-ep-holds-live-procedures-for-the-first-time-in-an-overseas-market
MicroPort®️ EP Holds Live Procedures for the First Time in Overseas Market
2020 Annual Results
MicroPort® Announces its Annual Results for 2020
First Implantation of Castor® Branched Stent-Graft System by MicroPort Endovastec™ Completed in Italy
Sino-Thai Cardiovascular Professional Corridor Successfully Held in Nanjing First Hospital
MicroPort® CardioFlow Reports Annual Results for 2020️-lp-stent-graft-system-completed-in-turkey
First Implantation of Endovastec™ Hercules®️-LP Stent Graft System Completed in Turkey
First Implantation of Endovastec™ Castor™ Stent Completed in Argentina
MicroPort CRM receives CE mark approval for Alizea™ and Borea™ pacemakers under the new European Medical Device Regulation
MicroPort® Among First to be Named “Medical Device Education Base” by the NMPA Institute of Executive Development
Horizon Medical® Orkid® Intrauterine Insemination Catheter Approved for Marketing
MicroPort® NeuroTech Closes Equity Investment in Rapid Medical, Becoming the Largest Shareholder
MicroPort® Wins German iF Product Design Award️-ep-contact-force-sensing-catheter
Subject Enrollment Completed for Clinical Trial of MicroPort®️ EP Contact Force-Sensing Catheter
CardioFlow Medtech Held VitaFlow® Online Serial Seminar in Guangdong Province
A remarkable presence of MicroPort® CRM at the European EHRA congress
A 100-Year-Old Patient Received MSC Rega™ Pacemaker Implantation
MicroPort® RehabTech Group holds its Inauguration Ceremony in Shanghai
EuroPCR 2021 announced the 4-year long term follow-up results of TARGET AC study with Firehawk® coronary rapamycin targeted eluting stent system
FUTURE-II Trial shows MicroPort®'s Firesorb® bioresorbable scaffold is comparable in angiographic and clinical efficacy to the world’s leading coronary drug-eluting stents
MicroPort® Firehawk Liberty™ Registration Approved in Belarus
Surgeries Performed by MicroPort® EP Columbus® 3D EP Navigation System Exceed 20,000 Cases Globally
MicroPort® NeuroTech Numen® System and Controller Receive CE Mark
MicroPort® Launches Multiple Symposia at CIT 2021
MicroPort® EP Receives Registration Approval from Kazakhstan Ministry of Health for Multiple Products
MicroPort® EP Columbus® 3D EP Navigation System Successfully Performs First Procedure in Brazil
MicroPort® Products Showcases at China Indigenous Brand Expo
MicroPort® RIC MedTech Exhibits at CMEF 2021
MicroPort® wins Italy A' Design Award
Microport® announces the First Patients Enrolled in the European TARGET FIRST Clinical Trial of the Firehawk™ Coronary Stent
MicroPort® Subsidiary EndoPhix® Performs World’s First Permanently Implanted Balloon Rotator Cuff Functional Reconstruction Surgery
CardioFlow Medtech, Announces Four-Year Follow-Up Results of VitaFlow® Clinical Trial during CIT 2021
MicroPort® Orthopedics holds joint workshop on joint surgery with China-Japan Friendship Hospital
2020 Annual Report
MicroPort® Orthopedics at the 13th Annual Congress of the Chinese Association of Orthopedic Surgeons (CAOS 2021)
MicroPort® EP Attends the 9th All-Russian Congress of Arrhythmology
MicroPort® EP Successfully Performs First Procedure in Belgium
Firehawk Liberty™ Receives Registration Approval in Colombia
MicroPort® Participates in OCC 2021 and Announces One-Year Results of Firesorb® Pivotal Study FUTURE-II
MicroPort® EP IceMagic® Cardiac Cryoablation System Enters “Green Path”
MicroPort® MedBot DFVision® 3D Electronic Laparoscope Approved for Marketing by NMPA
MicroPort CRM announces European launch of Alizea™ and Borea™ pacemakers with Bluetooth® connectivity and streamlined remote monitoring
First Implantation of Endovastec Minos Stent Graft System Completed in Brazil
Endovastec™ Joins ICARUS 2021 Symposium
MicroPort® EP Held the First Session of “Columbus Elite Surgeons Club”
MSC Organized “If Pacemakers Could Talk” in Nanchang
Firehawk® Receives Registration Approval in Venezuela
CAPRI Clinical Investigation of ENO™/TEO™/OTO™ Pacing System by MicroPort® CRM Completes First Enrollment of Chinese Patients
MicroPort® Listed Among “China’s 500 Most Valuable Brands” List Again for 2021
MicroPort® Orthopedics Receives “15A” ODEP Rating for its Advance® Medial-Pivot Knee System
Subject Enrolment Completed for MicroPort® EP Cardiac Cryoablation System Trial
MSC Completed the 1st Rega Series Pacemaker Implantation in Chifeng, China
MicroPort® Shared the Use of Firehawk® and Firefighter™ in Complex Lesions at the 16th Ice City Conference of Cardiology (ICC2021)
MicroPort® NeuroTech Presents Two New Products at the 7th CSA Annual Academic Conference
MicroPort® EP Represented in the 19th International Forum on Atrial Fibrillation
Endovastec™ Attends the Third CMDA-CACVS Annual Academic Congress
MicroPort® Cardiac Rhythm Management Business Announces US$150 Million Series C Investment
CardioFlow Medtech Makes Follow-on Investment in Transcatheter Valve Start-up Valcare
First Implantation of Castor® Branched Stent-Graft System by MicroPort Endovastec™ Completed in Brazil
MicroPort® Lifesciences Showcases Two Products at the 10th CSE Academic Conference on Diabetes and Gonadal Disorders
MicroPort® Wewin Receives CE Mark for its 2019-nCoV PCR Test Kit
Endovastec™ Receives ISO 50001 Energy Management System Certificate
Endovastec™ Minos® Stent Graft System Completes First Clinical Implantation in Czech Republic
Lei Jiang
Xiaoming Zhu
Cardiac Rhythm Management
Pacemakers. ICD devices. CRT devices. A cardiac lead. MicroPort CRM provides you with SMARTVIEW – a complete solution for patient management. Arrhythmia assessment...
Subject Enrollment Completed for the MicroPort® NeuroTech Tubridge® Vascular Reconstruction Device IMPACT Study
CardioFlow Medtech’s Next-generation Alwide® Plus Balloon Catheter Approved for Marketing in China
Firehawk®, Foxtrot® NC and Foxtrot® Pro PTCA Balloon Catheters Receive Approval in Turkmenistan
Contact details
Ulys™ Brochure
Edis™ Brochure
Platinium™ Brochure
Longevity Brochure
Gali 4LV SonR™ Brochure
Platinium 4LV SonR™ Brochure
Platinium 4LV™ US Brochure
MicroPort® Attends at SOLACI-CACI 2021 with CardioFlow Medtech™ and Endovastec™
MSC Completes First Patient Enrollment for Multicenter Post-Marketing Clinical Study ‘China Pace’
MicroPort® EP OptimAblate™ Tubing Set Receives NMPA Marketing Approval
2021 Interim Results
MicroPort® EP and Stereotaxis Collaborate to Advance Innovation and Adoption of Robotic Electrophysiology in China
MicroPort® Announces 2021 Interim Results
CardioFlow Medtech Announces 2021 Interim Results
MicroPort® NeuroTech Completes First Implantation of NUMEN® Coil Embolization System in Chile, Marking Their Debut in an Overseas Market
MicroPort® Announces Strategic Investment with Kerui Pharma
MicroPort® EP Products Debut in First Procedure in Kazakhstan
MicroPort® NeuroTech NUMEN Coil Embolization System Approved for Market in Korea
Gali 4LV™ Brochure
Gali 4LV™ Brochure
MicroPort® Toumai® Laparoscopic Surgery Robot Becomes First in China to Complete Experimental Sleeve Lobectomy in Animals
First Motorized Retrievable Transcatheter Aortic Valve (TAVI) System - VitaFlow Liberty™ received approval for marketing in China
Products Complete First Implantations in the UK Following Endovastec’s Entry into the UK Market
MicroPort® Completes Subject Enrollment for Firesorb® FUTURE-III Pivotal Trial
MicroPort® Acquires German ECLS Company Hemovent® GmbH and Invests in Expansion of German Operations
Chinese-developed Honghu Orthopedic Surgical Robot Completes First 5G Remote Joint Replacement Surgery
C Lowry Barnes, M.D. Joins MicroPort® Orthopedics as Medical Director
MicroPort® Purchases Property for Miracle Point Innovation Center for New Materials and Medical Devices
Construction Begins on 280,000-Square-Meter MicroPort® MegaFactory and Global Medical Experience Center
MicroPort® social media community guidelines
VitaFlow Liberty™ Completes Implantations across 15 Hospitals on the First Day after Market Launch
MicroPort® Shared Latest Research Results at China Heart Congress (CHC) and 6th China Vascular Congress (CVC)
Clinical Trial Enrollment Completed for the First Endovastec™ Venous Stent
MicroPort® Orthopedics Receives FDA 510(k) Approval for Two Hip Products
MicroPort® CRM Announces Completion of Patient Recruitment for the Primary Objectives of the Apollo Study on Invicta Defibrillation Lead
Endovastec™ Debuts at Pan-American Congress on Vascular and Endovascular Surgery
Multicenter Clinical Trial Kicks Off for MicroPort® Toumai® Laparoscopic Surgery Robot
MicroPort® Makes Strategic Investment in Intravascular Imaging Start-up Argus
MicroPort® Expands MIH in Suzhou Industrial Park to Build Strategic Strength for Original Innovation of High-Tech Medical Solutions
MicroPort® Hosts Teleconference of TARGET PREMIER Study on Next Generation Rapamycin Target Eluting Stent
MicroPort® CardioFlow Medtech Launches VitaFlow Liberty™ at China Structural Week
Top-tier Surgical Robot Company MicroPort MedBot Debuts on Main Board of HKEX
CardioFlow Medtech Increases Investment in US Structural Heart Disease Innovator 4C Medical
MicroPort® Toumai® Successfully Performed Difficult Procedures for Registered Multidisciplinary Clinical Trials
MicroPort® MedBot Attends CUA 2021 with MicroPort® Urocare
MicroPort® NeuroTech Participates in 2021 OCIN as Tubridge® Used in Over 5,000 Clinical Cases
MicroPort® Presents Argus OCT at the 32nd GW-ICC Entering the Era of Precision PCI
MicroPort® Establishes Headquarters for the Americas in USA, with Southern California Innovation Center and Intelligent Manufacturing Base
MicroPort® MedBot Enters into Strategic Cooperation Agreement with South China Hospital affiliated to Shenzhen University
First DSA System of MicroImaging® Receives NMPA Marketing Approval
MicroPort® Holds National Investigator Kick-Off Meeting for PROMISE-BIF Clinical Trial of Rapamycin Coronary Balloon Catheter
MicroPort® Launches Firehawk IN™ as First Local India-manufactured DES for India Market
Ryflumen®, First Peripheral High-Pressure Balloon Dilatation Catheter of Endovastec™, Approved for Marketing by NMPA
CardioFlow Medtech Participates in the 32nd GW-ICC, Drawing Expert Attention on Clinical Application of Motorized Retrievable Valve System
MicroPort® Kewei Membrane Oxygenator Gains Access to China’s Special Approval Procedure for Innovative Medical Devices
MicroPort® NeuroTech Completes Strategic Financing with Shareholder Structure Optimization, as Foundation for Next-Step Global Expansion
MicroPort® Orthopedics Zirconium-Niobium Alloy Femoral Head Gains Access to China’s Special Approval Procedure for Innovative Medical Devices
Vflower™, First Venous Stent System by MicroPort® Endovastec, Gains Access to China’s Special Approval Procedure for Innovative Medical Devices
MicroPort® Achieves 1 Million-Set Global Orders and Shipments of Coronary Stent Systems, Expected to be Global Top 2 in Market Share
MicroPort® MedBot Launches DFVision® 3D Electronic Laparoscope at the 28th National Seminar for Laparoscopic Surgery Demonstration
MicroPort® Announces Multiple Results from the TARGET Clinical Study on Firehawk® Stent at TCT 2021
MicroPort® Coronary Balloon Dilation Catheters Firefighter™ and Firefighter™ NC Approved for Marketing in Colombia
MicroPort® RehabTech TherMotion® Cryo-Thermo Compression Device Approved for Marketing in China
Mona Lisa Robotic Prostate Puncture System Completes Enrollment of First Case for Clinical Trial
MicroPort® NeuroTech Obtains KGMP Certification
MicroPort® MedBot® Announces the Completion of the First Confirmatory Clinical Trial of the R-ONE® Vascular Interventional Surgical Robot in China
MicroPort® Orthopedics Celebrates First Hip Replacement Surgery in Brazil Using the MicroPort® AnteriorPath® Technique
Article on Clinical Use of Endovastec™ Castor™ Stent First Featured in International Medical Journal
Jing Xie
Rob Cripe
Jean-Marc D’Hondt
Irene Chiu

CRM Tech Corner - CRT

CRM Tech Corner - ICD devices

CRM Tech Corner - CRT-P
CRT-D devices features and algorithms
CRT-P devices features and algorithms
Pacemakers features and algorithms
ICD devices features and algorithms
New Therapies

Our therapy copy
CRM Education & training
Ethics hotline
Code of conduct
Industry affiliations
Gender Equality
MicroPort® CRM Receives CE Mark Approval for NAVIGO™ Left Ventricular Pacing Leads
ALIZEA™ | Connected yet free
Alizea comes with SmartView ConnectTM, an innovative Bluetooth remote monitoring system that offers advanced patient monitoring and follow-up, providing timely...
Cybersecurity PGP
Endovastec™ Fontus™ System Approved for Marketing by NMPA
MicroPort®’s Four Sports Medicine Products Approved for Marketing
MicroPort NeuroTech™ Bridge® Vertebral Drug-Eluting Stent Presents in Frontiers in Neurology with PESS Results
MicroPort® MedBot® Completes the First Enrollment in Toumai® Single-Arm Surgical Robot Trial
MicroPort® Firehawk® Stent System Approved for Marketing in Australia
Endovastec™ Receives Approval for Hercules™-LP Stent Graft System in India
MicroPort® MedBot® Conducts Animal Testing Using Unmanned, Fully Automated Surgical Platform Madame Curie™ and Achieves Initial Success
Results of Pre-Market Clinical Trial “CATCH” for MicroPort NeuroTech™ NUMEN® Coil Embolization System Published in World Neurosurgery
MicroPort® MedBot® Toumai® Mobile Showing & Training Center Launched
MicroPort® CRM Receives Approval in Japan for Alizea™ Bluetooth® Pacemaker
Endovastec™ Talos™ Thoracic Stent Graft System Receives NMPA Approval for Marketing
VitaFlow Liberty™ by MicroPort® CardioFlow Medtech Obtains Approval in Argentina
Alice Flacco
Subject Enrollment Completed for Pre-market Clinical Study of MSC’s BonaFire® Lead
MicroPort® Orthopedics China Develops "Personalized" Artificial Wrist Prosthesis
Contact details
CRM Contact Us
MicroPort® Orthopedics Receives NMPA Marketing Approval for its Procotyl®-L Acetabular Cup System and Profemur® Preserve Hip Stem
MicroPort® Toumai® Surgical Robot Receives NMPA Approval, Becoming the First Commercialized Four-Arm Laparoscopic Surgical Robot Developed in China
MicroPort® HorizonMedical™ Receives Marketing Approval for Two Oocyte Retrieval Needles
MicroPort® RehabTech Launches New Integrated Musculoskeletal Rehabilitation Solution
Toumai® Laparoscopic Surgical Robot by MicroPort® MedBot® Completes Enrollment for Multidisciplinary, Multicenter-Registered Clinical Trials
TARGET PREMIER Clinical Study for MicroPort® Next Generation Rapamycin Target Eluting Stent Completes First Patient Enrollment
MicroPort® Holds Singapore LIVE 2022 Satellite Session on Complex Lesions
World’s First Combined Single-Session Transcatheter Aortic Procedure Using VitaFlow® Reported in JACC
REVEDA Establishes Joint Venture with Hybio Pharmaceutical on Drug-Device Combination Products
Single-Use Flexible Ureteropelvic Electronic Endoscopic Catheter developed by MicroPort® Urocare Approved for Marketing
First Patient Enrolled in MicroPort NueroTech™ PROMISE Study for Rebridge® Intracranial Visualized Stent
MicroPort NeuroTech™ Receives NMPA Marketing Approval for its NUMEN Silk® 3-D Coil Embolization System
MicroPort NeuroTech™ Receives NMPA Marketing Approval for its Diveer® Intracranial Balloon Catheter
Firehawk Liberty™ Receives Registration Approval in Egypt
MicroPort® MedBot® Announces Inclusion in Hang Seng Composite Index
Firehawk®, Foxtrot® NC and Foxtrot® Pro PTCA Balloon Catheters Receive Approval in Kyrgyzstan
MicroPort NeuroTech™ Obtains NMPA Marketing Approval for its Neurohawk® Stent Thrombectomy Device
CardioFlow Medtech Launches Prospective Multicenter Study on VitaFlow Liberty™ for Severe Aortic Valve Insufficiency
2021 Interim Report
2020 Interim Report
MicroPort NeuroTech™ NUMEN® Coil Embolization System Listed for Reimbursement under Korea’s National Health Insurance System
MicroPort® Urocare Obtains NMPA Marketing Approval for Ruyi Clip
First Clinical Implantation of Endovastec™’s Hercules®-LP Thoracic Stent Graft System Completed in India
CardioFlow Medtech Receives Approval for Alwide® Plus Balloon Catheter in Argentina
MicroPort® Enrolls First Patient in PROMISE-BIF Study to Investigate the Rapamycin Coronary Balloon Catheter for the Treatment of De Novo Coronary Artery Bifurcation Lesions
HorizonMedical™’s CryoX™ Vitrification Device Approved for Marketing
MicroPort® Orthopedics Obtains NMPA Marketing Approval for Two Knee System Products
2021 Annual Results
MicroPort® Lifesciences AutoEx® Chemotherapy Pump Obtains Marketing Approval from NMPA
MicroPort® Announces Annual Results for 2021
MicroPort® MedBot® Announces Annual Results for 2021
CardioFlow Medtech Announces Annual Results for 2021
Endovastec™ Announces Annual Results for 2021
Hyperflex® Balloon Catheter by Endovastec™ Receives Marketing Approval in Japan
Two MicroPort ® Products Receive Red Dot Design Award
MicroPort® MedBot® Robotic-Assisted Trans-bronchial Navigation System Used in First Clinical Trial
Jack Heeter
MicroPort NeuroTech™ Receives NMPA Marketing Approval for the X-track™ Intracranial Distal Access Catheter
Firehawk Liberty™ Receives Registration Approval in Peru
Endovastec™ Receives MDSAP Certificate for Brazil and Japan
MicroPort® CRM receives MRI-conditional CE mark for Ulys™ and Edis™ ICDs as well as for Gali™ CRT-Ds
CardioFlow Medtech’s Strategic Partner, 4C Medical Completes Multiple TMVR Procedures with AltaValve™ Using the Next Generation Low Profile Fully Retrievable Transseptal Delivery System
Three MicroPort® Products Win iF Design Award
MicroPort® Honghu Orthopedic Surgical Robot Obtains Marketing Approval from NMPA
Endovastec™ Holds Virtual Launch Meeting for Fontus™ Branched Surgical Stent Graft System
First Homegrown MRI-Conditional Pacemaker of MicroPort® MSC Receives NMPA Approval for Marketing
2021 Annual Report
MicroPort® Announces Latest Results from the OCT Clinical Study of Firehawk® Stent in High-Risk Populations at Euro-PCR 2022
Study on Hemovent GmbH's MOBYBOX® ECMO System for the Treatment of COVID-19 Patients Published in Leading International Medical Journal
MicroPort® Firehawk® Large-Scale Randomized Controlled Clinical Trial TARGET DAPT Completes Subject Enrollment
MicroPort® CRM’s Platinium™ ICD Receives NMPA Approval
MicroPort® MedBot® JV’s Mona Lisa Becomes First to Complete Multicenter Clinical Trial in China
Rob Cripe
Jean-Marc D’Hondt
Patrick Yu
Hemovent™ Showcases Product Portfolio on 10th EuroELSO congress in London
Hemovent™ Receives MDSAP Certificate for United States and Canada
MicroPort® MedBot® Announces the Completion of R-One® Vascular Interventional Surgical Robot Registrational Clinical Trial
MicroPort NeuroTech™ Completes First Implantation of Numen™ Coil Embolization System in the U.S.
MicroPort® Meets Global Industry Experts and Scholars in Paris and Presents Several Products at EuroPCR 2022
CardioFlow Medtech’s VitaFlow Liberty™ Wins Italian A' Design Award
CardioFlow Medtech’s Strategic Partner, 4C Medical, Releases Global Clinical Data on Early Feasibility Study of AltaValve™ Transcatheter Mitral Valve Replacement at AATS 2022
MicroPort Argus™ OCT System Officially Launched
Toumai® Completes the World's Longest-Range 5G Tele-Robotic Surgery
Endovastec™ Reewarm™ PTX DCB PTA Catheter Receives Marketing Approval in Brazil
MicroPort® Releases 2-Year Results of Firesorb® Pivotal Trial FUTURE II
MicroPort® CRM Receives CE Mark Approval for INVICTA™ Defibrillation Leads
MicroPort NeuroTech™ Debuts on Main Board of HKEX
Firehawk Pro™ Coronary Rapamycin Target Eluting Stent System Receives NMPA Approval for Marketing
MicroPort® Participates in CIT 2022 and Hosts Joint Satellite Session
Endovastec™ Presents Flagship Products at CICE 2022
MSC Announces the First Clinical Use of TheFirst Rega™ MRI-Conditional Implantable Pacemaker in China
MicroPort® MedBot™ JV’s R-ONE™ Vascular Interventional Surgical Robot Completes Registration Clinical Trial
VitaFlow Liberty™ by CardioFlow Medtech Obtains Marketing Approval in Colombia
MicroPort NeuroTech™ APOLLO™ Intracranial Arterial Stent System Completed First Implantation in Brazil
MicroPort NeuroTech™ Completes First Implantations of NUMEN™ Coil Embolization System in Poland
MicroPort NeuroTech™ NUMEN Coil Embolization System Receives Marketing Approval in Japan
MicroPort EP Listed on the SSE STAR Market
Endovastec™ Announces 2022 Interim Results
MicroPort NeuroTech™ Announces 2022 Interim Results
MicroPort® MedBot™ Announces 2022 Interim Results
2022 Interim Results
Endovastec™ Minos™ Abdominal Aortic Stent-Graft and Delivery System Receives Approval for Marketing in Colombia
MicroPort® Announces 2022 Interim Results
CardioFlow Medtech Announces 2022 Interim Results
MicroPort® MedBot™ Listed among the "50 Smartest Companies" in MIT Technology Review
MicroPort® Announces Important Follow-up Results at ESC Congress 2022
TARGET IV-NA Clinical Trial for the Firehawk™ Stent Completes the Last Enrollment
6 Endovastec™ Products Approved for Marketing in Belarus
MicroPort® MedBot® SkyWalker™ Orthopedic Surgical Robot Obtains CE Marking in EU
MicroPort® MedBot® Performs World's First Robotic Positioned Cryoablation of Prostate Cancer
Endovastec™ Completes First Pre-market Clinical Implantation of TIPS Stent Graft System
MicroPort® Coronary Balloon Catheters Receive Marketing Approval in Peru
MicroPort® Coronary Foxtrot™ NC Balloon Catheter Approved for Sale in Indonesia
Endovastec™ Minos® Abdominal Aortic Stent-Graft and Delivery System Receives Approval for Marketing in South Korea
Firehawk Liberty™ Rapamycin Target Eluting Coronary Stent System Approved for Marketing in Russia
2022 Interim Report
VitaFlow Liberty™ and Alwide® Plus by CardioFlow Medtech Obtain Marketing Approval in Thailand
ArgusClarity™ OCT System by MicroPort Argus™ Registered for Marketing in Singapore
First Implantation of Endovastec™'s Castor™ Branched Aortic Stent-Graft System Completed in Netherlands
MicroPort EP Obtains FDA Approval for EasyFinder™ Fixed Curve Diagnostic Catheter
MicroPort® Joins Singapore LIVE 2023
HorizonMedical™’s Daylily® Embryo Transfer Catheter Obtains FDA 510(k) Approval